QUARTERLY REPORT
Q3 2025 — Quarterly report (Form 10-Q)
Q3 2025PDF · 73 pages578 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2025
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________to__________
Commission
File Number Exact Name of Registrant as Specified in its Charter,
Principal Office Address and Telephone Number
State or Other
Jurisdiction of
Incorporation
or Organization I.R.S. Employer
Identification No.
001-38646 Dow Inc. Delaware 30-1128146
2211 H.H. Dow Way, Midland, MI 48674
(989) 636-1000
001-03433 The Dow Chemical Company Delaware 38-1285128
2211 H.H. Dow Way, Midland, MI 48674
(989) 636-1000
Securities registered pursuant to Section 12(b) of the Act:
Registrant Title of each class Trading
Symbol(s) Name of each exchange on
which registered
Dow Inc. Common Stock, par value $0.01 per share DOW New York Stock Exchange
The Dow Chemical Company 0.500% Notes due March 15, 2027 DOW/27 New York Stock Exchange
The Dow Chemical Company 1.125% Notes due March 15, 2032 DOW/32 New York Stock Exchange
The Dow Chemical Company 1.875% Notes due March 15, 2040 DOW/40 New York Stock Exchange
The Dow Chemical Company 4.625% Notes due October 1, 2044 DOW/44 New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days.
Dow Inc. ☑ Yes ☐ No The Dow Chemical Company ☑ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period
that the registrant was required to submit such files).
Dow Inc. ☑ Yes ☐ No The Dow Chemical Company ☑ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller
reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Dow Inc.
Large
accelerated
filer ☑ Accelerated
filer ☐
Non-
accelerated
filer ☐
Smaller
reporting
company ☐
Emerging
growth
company ☐
The Dow Chemical
Company
Large
accelerated
filer ☐ Accelerated
filer ☐
Non-
accelerated
filer ☑
Smaller
reporting
company ☐
Emerging
growth
company ☐
Table of Contents
1
-- 1 of 73 --
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Dow Inc. ☐ The Dow Chemical Company ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Dow Inc. ☐ Yes ☑ No The Dow Chemical Company ☐ Yes ☑ No
Dow Inc. had 710,767,392 shares of common stock, $0.01 par value, outstanding at September 30, 2025. The Dow Chemical
Company had 100 shares of common stock, $0.01 par value, outstanding at September 30, 2025, all of which were held by the
registrant’s parent, Dow Inc.
The Dow Chemical Company meets the conditions set forth in General Instruction H(1)(a) and (b) for Form 10-Q and therefore is
filing this form with the reduced disclosure format.
Table of Contents
2
-- 2 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
QUARTERLY REPORT ON FORM 10-Q
For the quarterly period ended September 30, 2025
TABLE OF CONTENTS
PAGE
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements. 5
Dow Inc. and Subsidiaries:
Consolidated Statements of Income. 5
Consolidated Statements of Comprehensive Income. 6
Consolidated Balance Sheets. 7
Consolidated Statements of Cash Flows. 8
Consolidated Statements of Equity. 9
The Dow Chemical Company and Subsidiaries:
Consolidated Statements of Income. 10
Consolidated Statements of Comprehensive Income. 11
Consolidated Balance Sheets. 12
Consolidated Statements of Cash Flows. 13
Consolidated Statements of Equity. 14
Dow Inc. and Subsidiaries and The Dow Chemical Company and Subsidiaries:
Notes to the Consolidated Financial Statements. 15
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of
Operations. 45
Results of Operations. 48
Changes in Financial Condition. 55
Other Matters. 62
Item 3. Quantitative and Qualitative Disclosures About Market Risk. 63
Item 4. Controls and Procedures. 63
PART II – OTHER INFORMATION
Item 1. Legal Proceedings. 64
Item 1A. Risk Factors. 65
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 66
Item 4. Mine Safety Disclosures. 66
Item 5. Other Information. 66
Item 6. Exhibits. 67
SIGNATURE 68
Table of Contents
3
-- 3 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company
and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the "Company") due to the parent/
subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to
both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this
report on its own behalf and neither company makes any representation to the information relating to the other
company.
CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS
Certain statements in this report are “forward-looking statements” within the meaning of the federal securities laws,
including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Such statements often address expected future business and financial performance, financial
condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” "could," “estimate,”
“expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,”
“will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or
phrases.
Forward-looking statements are based on current assumptions and expectations of future events that are subject to
risks, uncertainties and other factors that are beyond Dow’s control, which may cause actual results to differ
materially from those projected, anticipated or implied in the forward-looking statements and speak only as of the
date the statements were made. These factors include, but are not limited to: sales of Dow’s products; Dow’s
expenses, future revenues and profitability; any sanctions, export restrictions, supply chain disruptions or increased
economic uncertainty related to the ongoing conflicts between Russia and Ukraine and in the Middle East; capital
requirements and need for and availability of financing; unexpected barriers in the development of technology,
including with respect to Dow's contemplated capital and operating projects; Dow's ability to realize its commitment to
carbon neutrality on the contemplated timeframe, including the completion and success of its integrated ethylene
cracker and derivatives facility in Alberta, Canada; size of the markets for Dow’s products and services and ability to
compete in such markets; Dow's ability to develop and market new products and optimally manage product life
cycles; the rate and degree of market acceptance of Dow’s products; significant litigation and environmental matters
and related contingencies and unexpected expenses; the success of competing technologies that are or may
become available; the ability to protect Dow’s intellectual property in the United States and abroad; developments
related to contemplated restructuring activities and proposed divestitures or acquisitions such as workforce reduction,
manufacturing facility and/or asset closure and related exit and disposal activities, and the benefits and costs
associated with each of the foregoing; fluctuations in energy and raw material prices; management of process safety
and product stewardship; changes in relationships with Dow’s significant customers and suppliers; changes in public
sentiment and political leadership; increased concerns about plastics in the environment and lack of a circular
economy for plastics at scale; changes in consumer preferences and demand; changes in laws and regulations,
political conditions, tariffs and trade policies, or industry development; global economic and capital markets
conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity
prices; business, logistics and supply disruptions; security threats, such as acts of sabotage, terrorism or war,
including the ongoing conflicts between Russia and Ukraine and in the Middle East; weather events and natural
disasters; disruptions in Dow’s information technology networks and systems, including the impact of cyberattacks;
risks related to Dow’s separation from DowDuPont Inc. such as Dow’s obligation to indemnify DuPont de Nemours,
Inc. and/or Corteva, Inc. for certain liabilities; and any global and regional economic impacts of a pandemic or other
public health-related risks and events on Dow’s business.
Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such
expectation or belief is based on the current plans and expectations of management and expressed in good faith and
believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be
achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results
and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors”
contained in Part II, Item 1A of this Quarterly Report on Form 10-Q and in Part I, Item 1A of the Company’s Annual
Report on Form 10-K for the year ended December 31, 2024. These are not the only risks and uncertainties that Dow
faces. There may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not
currently expect to have a material impact on its business. If any of those risks or uncertainties develops into an
actual event, it could have a material adverse effect on Dow’s business. Dow Inc. and TDCC assume no obligation to
update or revise publicly any forward-looking statements whether because of new information, future events, or
otherwise, except as required by securities and other applicable laws.
Dow's website and its content are not deemed incorporated by reference into this report.
Table of Contents
4
-- 4 of 73 --
PART I – FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Dow Inc. and Subsidiaries
Consolidated Statements of Income
Three Months Ended Nine Months Ended
In millions, except per share amounts (Unaudited)
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net sales $ 9,973 $ 10,879 $ 30,508 $ 32,559
Cost of sales 9,242 9,809 28,523 28,888
Research and development expenses 191 208 579 608
Selling, general and administrative expenses 340 396 1,053 1,228
Amortization of intangibles 46 76 185 234
Restructuring and asset related charges - net 23 24 822 69
Equity in earnings (losses) of nonconsolidated affiliates (72) 2 (122) 45
Sundry income (expense) - net 185 119 345 256
Interest income 47 36 114 143
Interest expense and amortization of debt discount 221 199 646 595
Income (loss) before income taxes 70 324 (963) 1,381
Provision (credit) for income taxes (54) 84 4 145
Net income (loss) 124 240 (967) 1,236
Net income attributable to noncontrolling interests 62 26 113 67
Net income (loss) available for Dow Inc. common stockholders $ 62 $ 214 $ (1,080) $ 1,169
Per common share data:
Earnings (loss) per common share - basic $ 0.08 $ 0.30 $ (1.53) $ 1.65
Earnings (loss) per common share - diluted $ 0.08 $ 0.30 $ (1.53) $ 1.65
Weighted-average common shares outstanding - basic 711.8 702.3 709.4 703.5
Weighted-average common shares outstanding - diluted 713.2 703.6 709.4 704.9
Depreciation $ 536 $ 501 $ 1,586 $ 1,470
Capital expenditures $ 564 $ 736 $ 1,911 $ 2,173
See Notes to the Consolidated Financial Statements.
Table of Contents
5
-- 5 of 73 --
Dow Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income
Three Months Ended Nine Months Ended
In millions (Unaudited)
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net income (loss) $ 124 $ 240 $ (967) $ 1,236
Other comprehensive income (loss), net of tax
Unrealized gains on investments 57 34 67 89
Cumulative translation adjustments (33) 199 218 34
Pension and other postretirement benefit plans 28 18 69 52
Derivative instruments 11 31 (7) 3
Total other comprehensive income 63 282 347 178
Comprehensive income (loss) 187 522 (620) 1,414
Comprehensive income attributable to noncontrolling interests,
net of tax 62 26 113 67
Comprehensive income (loss) attributable to Dow Inc. $ 125 $ 496 $ (733) $ 1,347
See Notes to the Consolidated Financial Statements.
Table of Contents
6
-- 6 of 73 --
Dow Inc. and Subsidiaries
Consolidated Balance Sheets
In millions, except share amounts (Unaudited)
Sep 30,
2025 Dec 31,
2024
Assets
Current Assets
Cash and cash equivalents $ 4,609 $ 2,189
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2025: $71; 2024: $95) 5,044 4,756
Other 2,117 2,108
Inventories 6,675 6,544
Other current assets 1,201 993
Total current assets (variable interest entities restricted - 2025: $219; 2024: $55) 19,646 16,590
Investments
Investment in nonconsolidated affiliates 1,255 1,266
Other investments (investments carried at fair value - 2025: $2,073; 2024: $2,047) 2,812 3,033
Noncurrent receivables 427 380
Total investments 4,494 4,679
Property
Property 65,327 62,121
Less: Accumulated depreciation 42,788 40,117
Net property (variable interest entities restricted - 2025: $2,357; 2024: $122) 22,539 22,004
Other Assets
Goodwill 8,690 8,565
Other intangible assets (net of accumulated amortization - 2025: $5,702; 2024: $5,394) 1,546 1,721
Operating lease right-of-use assets 1,314 1,268
Deferred income tax assets 1,418 1,257
Deferred charges and other assets 1,343 1,228
Total other assets (variable interest entities restricted - 2025: $232; 2024: $15) 14,311 14,039
Total Assets $ 60,990 $ 57,312
Liabilities and Equity
Current Liabilities
Notes payable $ 133 $ 135
Long-term debt due within one year 413 497
Accounts payable:
Trade 4,535 4,847
Other 1,673 1,694
Operating lease liabilities - current 324 318
Income taxes payable 271 276
Accrued and other current liabilities 2,755 2,521
Total current liabilities (variable interest entities nonrecourse - 2025: $413; 2024: $24) 10,104 10,288
Long-Term Debt (variable interest entities nonrecourse - 2025: $172; 2024: $—) 17,709 15,711
Other Noncurrent Liabilities
Deferred income tax liabilities 383 392
Pension and other postretirement benefits - noncurrent 4,656 4,736
Asbestos-related liabilities - noncurrent 645 713
Operating lease liabilities - noncurrent 1,046 984
Other noncurrent obligations 7,383 6,637
Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $353; 2024: $13) 14,113 13,462
Stockholders’ Equity
Common stock (authorized 5,000,000,000 shares of $0.01 par value each;
issued 2025: 785,965,252 shares; 2024: 784,471,939 shares) 8 8
Additional paid-in capital 11,099 9,203
Retained earnings 18,576 20,909
Accumulated other comprehensive loss (7,763) (8,110)
Treasury stock at cost (2025: 75,197,860 shares; 2024: 80,859,145 shares) (4,379) (4,655)
Dow Inc.’s stockholders’ equity 17,541 17,355
Noncontrolling interests 1,523 496
Total equity 19,064 17,851
Total Liabilities and Equity $ 60,990 $ 57,312
See Notes to the Consolidated Financial Statements.
Table of Contents
7
-- 7 of 73 --
Dow Inc. and Subsidiaries
Consolidated Statements of Cash Flows
In millions (Unaudited)
Nine Months Ended
Sep 30,
2025 Sep 30,
2024
Operating Activities
Net income (loss) $ (967) $ 1,236
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization 2,126 2,143
Credit for deferred income tax (179) (134)
Earnings of nonconsolidated affiliates less than dividends received 312 221
Net periodic pension benefit credit (73) (143)
Pension contributions (145) (92)
Net gain on sales of assets, businesses and investments (211) (58)
Restructuring and asset related charges - net 822 69
Other net loss 134 332
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable (400) (818)
Inventories (132) (676)
Accounts payable (492) 601
Other assets and liabilities, net (31) (589)
Cash provided by operating activities - continuing operations 764 2,092
Cash provided by (used for) operating activities - discontinued operations (16) 8
Cash provided by operating activities 748 2,100
Investing Activities
Capital expenditures (1,911) (2,173)
Proceeds from incentives related to capital expenditures 132 —
Investment in gas field developments (110) (157)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested 135 36
Acquisitions of property and businesses, net of cash acquired — (121)
Investments in and loans to nonconsolidated affiliates (21) (25)
Proceeds from sales of ownership interests in nonconsolidated affiliates 125 —
Purchases of investments (523) (1,381)
Proceeds from sales and maturities of investments 711 2,386
Other investing activities, net 5 (21)
Cash used for investing activities (1,457) (1,456)
Financing Activities
Changes in short-term notes payable 36 (61)
Proceeds from issuance of short-term debt greater than three months 50 114
Payments on short-term debt greater than three months (46) (6)
Proceeds from issuance of long-term debt 2,652 1,443
Payments on long-term debt (1,207) (224)
Collections on securitization programs, net of remittances (3) 28
Purchases of treasury stock — (494)
Proceeds from issuance of stock — 51
Transaction financing, debt issuance and other costs (130) (13)
Employee taxes paid for share-based payment arrangements (16) (38)
Distributions to noncontrolling interests (93) (49)
Proceeds from sale of noncontrolling interests 2,943 —
Dividends paid to stockholders (1,239) (1,474)
Other financing activities, net (6) —
Cash provided by (used for) financing activities 2,941 (723)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 259 18
Summary
Increase (decrease) in cash, cash equivalents and restricted cash 2,491 (61)
Cash, cash equivalents and restricted cash at beginning of period 2,263 3,048
Cash, cash equivalents and restricted cash at end of period $ 4,754 $ 2,987
Less: Restricted cash and cash equivalents, included in "Other current assets" 145 104
Cash and cash equivalents at end of period $ 4,609 $ 2,883
See Notes to the Consolidated Financial Statements.
Table of Contents
8
-- 8 of 73 --
Dow Inc. and Subsidiaries
Consolidated Statements of Equity
Three Months Ended Nine Months Ended
In millions, except per share amounts (Unaudited)
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Common Stock
Balance at beginning and end of period $ 8 $ 8 $ 8 $ 8
Additional Paid-in Capital
Balance at beginning of period 10,758 9,012 9,203 8,880
Common stock issued/sold — — — 51
Stock-based compensation 97 86 293 285
Treasury stock issuances - compensation and benefit plans (96) (43) (276) (161)
Sale of membership interest in Diamond Infrastructure Solutions
(Note 17) 339 — 1,879 —
Other 1 — — —
Balance at end of period 11,099 9,055 11,099 9,055
Retained Earnings
Balance at beginning of period 18,766 21,739 20,909 21,774
Net income (loss) available for Dow Inc. common stockholders 62 214 (1,080) 1,169
Dividends to stockholders (249) (490) (1,239) (1,474)
Common control transaction — — — 10
Other (3) (4) (14) (20)
Balance at end of period 18,576 21,459 18,576 21,459
Accumulated Other Comprehensive Loss
Balance at beginning of period (7,826) (7,785) (8,110) (7,681)
Other comprehensive income 63 282 347 178
Balance at end of period (7,763) (7,503) (7,763) (7,503)
Treasury Stock
Balance at beginning of period (4,475) (4,656) (4,655) (4,374)
Treasury stock purchases — (95) — (495)
Treasury stock issuances - compensation and benefit plans 96 43 276 161
Balance at end of period (4,379) (4,708) (4,379) (4,708)
Dow Inc.'s stockholders' equity 17,541 18,311 17,541 18,311
Noncontrolling Interests 1,523 530 1,523 530
Total Equity $ 19,064 $ 18,841 $ 19,064 $ 18,841
Dividends declared per share of common stock $ 0.35 $ 0.70 $ 1.75 $ 2.10
See Notes to the Consolidated Financial Statements.
Table of Contents
9
-- 9 of 73 --
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income
Three Months Ended Nine Months Ended
In millions (Unaudited)
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net sales $ 9,973 $ 10,879 $ 30,508 $ 32,559
Cost of sales 9,241 9,800 28,520 28,877
Research and development expenses 191 208 579 608
Selling, general and administrative expenses 340 396 1,053 1,228
Amortization of intangibles 46 76 185 234
Restructuring and asset related charges - net 23 24 822 69
Equity in earnings (losses) of nonconsolidated affiliates (72) 2 (122) 45
Sundry income (expense) - net 184 118 360 253
Interest income 47 38 117 152
Interest expense and amortization of debt discount 221 199 646 595
Income (loss) before income taxes 70 334 (942) 1,398
Provision (credit) for income taxes (54) 84 4 145
Net income (loss) 124 250 (946) 1,253
Net income attributable to noncontrolling interests 62 26 113 67
Net income (loss) available for The Dow Chemical Company
common stockholder $ 62 $ 224 $ (1,059) $ 1,186
Depreciation $ 536 $ 501 $ 1,586 $ 1,470
Capital expenditures $ 564 $ 736 $ 1,911 $ 2,173
See Notes to the Consolidated Financial Statements.
Table of Contents
10
-- 10 of 73 --
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Comprehensive Income
Three Months Ended Nine Months Ended
In millions (Unaudited)
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net income (loss) $ 124 $ 250 $ (946) $ 1,253
Other comprehensive income (loss), net of tax
Unrealized gains on investments 57 34 67 89
Cumulative translation adjustments (33) 199 218 34
Pension and other postretirement benefit plans 28 18 69 52
Derivative instruments 11 31 (7) 3
Total other comprehensive income 63 282 347 178
Comprehensive income (loss) 187 532 (599) 1,431
Comprehensive income attributable to noncontrolling interests, net
of tax 62 26 113 67
Comprehensive income (loss) attributable to The Dow Chemical
Company $ 125 $ 506 $ (712) $ 1,364
See Notes to the Consolidated Financial Statements.
Table of Contents
11
-- 11 of 73 --
The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets
In millions, except share amounts (Unaudited) Sep 30,
2025 Dec 31,
2024
Assets
Current Assets
Cash and cash equivalents $ 4,609 $ 2,189
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2025: $71; 2024: $95) 5,044 4,756
Other 2,120 2,116
Inventories 6,675 6,544
Other current assets 1,162 960
Total current assets (variable interest entities restricted - 2025: $219; 2024: $55) 19,610 16,565
Investments
Investment in nonconsolidated affiliates 1,255 1,266
Other investments (investments carried at fair value - 2025: $2,073; 2024: $2,047) 2,812 3,033
Noncurrent receivables 421 374
Total investments 4,488 4,673
Property
Property 65,327 62,121
Less accumulated depreciation 42,788 40,117
Net property (variable interest entities restricted - 2025: $2,357; 2024: $122) 22,539 22,004
Other Assets
Goodwill 8,690 8,565
Other intangible assets (net of accumulated amortization - 2025: $5,702; 2024: $5,394) 1,546 1,721
Operating lease right-of-use assets 1,314 1,268
Deferred income tax assets 1,418 1,257
Deferred charges and other assets 1,343 1,228
Total other assets (variable interest entities restricted - 2025: $232; 2024: $15) 14,311 14,039
Total Assets $ 60,948 $ 57,281
Liabilities and Equity
Current Liabilities
Notes payable $ 133 $ 135
Long-term debt due within one year 413 497
Accounts payable:
Trade 4,535 4,847
Other 1,673 1,732
Operating lease liabilities - current 324 318
Income taxes payable 271 276
Accrued and other current liabilities 2,637 2,405
Total current liabilities (variable interest entities nonrecourse - 2025: $413; 2024: $24) 9,986 10,210
Long-Term Debt (variable interest entities nonrecourse - 2025: $172; 2024: $—) 17,709 15,711
Other Noncurrent Liabilities
Deferred income tax liabilities 383 392
Pension and other postretirement benefits - noncurrent 4,656 4,736
Asbestos-related liabilities - noncurrent 645 713
Operating lease liabilities - noncurrent 1,046 984
Other noncurrent obligations 7,243 6,503
Total other noncurrent liabilities (variable interest entities nonrecourse - 2025: $353: 2024: $13) 13,973 13,328
Stockholder's Equity
Common stock (authorized and issued 100 shares of $0.01 par value each) — —
Additional paid-in capital 11,798 9,626
Retained earnings 13,722 16,020
Accumulated other comprehensive loss (7,763) (8,110)
The Dow Chemical Company’s stockholder's equity 17,757 17,536
Noncontrolling interests 1,523 496
Total equity 19,280 18,032
Total Liabilities and Equity $ 60,948 $ 57,281
See Notes to the Consolidated Financial Statements.
Table of Contents
12
-- 12 of 73 --
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Cash Flows
In millions (Unaudited)
Nine Months Ended
Sep 30,
2025 Sep 30,
2024
Operating Activities
Net income (loss) $ (946) $ 1,253
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization 2,126 2,143
Credit for deferred income tax (179) (134)
Earnings of nonconsolidated affiliates less than dividends received 312 221
Net periodic pension benefit credit (73) (143)
Pension contributions (145) (92)
Net gain on sales of assets, businesses and investments (211) (58)
Restructuring and asset related charges - net 822 69
Other net loss 136 333
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable (400) (818)
Inventories (132) (676)
Accounts payable (492) 601
Other assets and liabilities, net (72) (583)
Cash provided by operating activities 746 2,116
Investing Activities
Capital expenditures (1,911) (2,173)
Proceeds from incentives related to capital expenditures 132 —
Investment in gas field developments (110) (157)
Proceeds from sales of property, businesses and consolidated companies, net of cash divested 135 36
Acquisitions of property and businesses, net of cash acquired — (121)
Investments in and loans to nonconsolidated affiliates (21) (25)
Proceeds from sales of ownership interests in nonconsolidated affiliates 125 —
Purchases of investments (523) (1,381)
Proceeds from sales and maturities of investments 711 2,386
Other investing activities, net 5 (21)
Cash used for investing activities (1,457) (1,456)
Financing Activities
Changes in short-term notes payable 36 (61)
Proceeds from issuance of short-term debt greater than three months 50 114
Payments on short-term debt greater than three months (46) (6)
Proceeds from issuance of long-term debt 2,652 1,443
Payments on long-term debt (1,207) (224)
Collections on securitization programs, net of remittances (3) 28
Proceeds from issuance of stock — 51
Transaction financing, debt issuance and other costs (130) (13)
Employee taxes paid for share-based payment arrangements (16) (38)
Distributions to noncontrolling interests (93) (49)
Proceeds from sale of noncontrolling interests 2,943 —
Dividends paid to Dow Inc. (1,237) (1,984)
Other financing activities, net (6) —
Cash provided by (used for) financing activities 2,943 (739)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 259 18
Summary
Increase (decrease) in cash, cash equivalents and restricted cash 2,491 (61)
Cash, cash equivalents and restricted cash at beginning of period 2,263 3,048
Cash, cash equivalents and restricted cash at end of period $ 4,754 $ 2,987
Less: Restricted cash and cash equivalents, included in "Other current assets" 145 104
Cash and cash equivalents at end of period $ 4,609 $ 2,883
See Notes to the Consolidated Financial Statements.
Table of Contents
13
-- 13 of 73 --
The Dow Chemical Company and Subsidiaries
Consolidated Statements of Equity
Three Months Ended Nine Months Ended
In millions (Unaudited)
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Common Stock
Balance at beginning and end of period $ — $ — $ — $ —
Additional Paid-in Capital
Balance at beginning of period 11,362 9,341 9,626 9,091
Issuance of parent company stock - Dow Inc. — — — 51
Stock-based compensation 97 86 293 285
Sale of membership interest in Diamond Infrastructure Solutions
(Note 17) 339 — 1,879 —
Balance at end of period 11,798 9,427 11,798 9,427
Retained Earnings
Balance at beginning of period 13,902 16,964 16,020 17,495
Net income (loss) available for The Dow Chemical Company
common stockholder 62 224 (1,059) 1,186
Dividends to Dow Inc. (240) (600) (1,225) (2,077)
Other (2) (3) (14) (19)
Balance at end of period 13,722 16,585 13,722 16,585
Accumulated Other Comprehensive Loss
Balance at beginning of period (7,826) (7,785) (8,110) (7,681)
Other comprehensive income 63 282 347 178
Balance at end of period (7,763) (7,503) (7,763) (7,503)
The Dow Chemical Company's stockholder's equity 17,757 18,509 17,757 18,509
Noncontrolling Interests 1,523 530 1,523 530
Total Equity $ 19,280 $ 19,039 $ 19,280 $ 19,039
See Notes to the Consolidated Financial Statements.
Table of Contents
14
-- 14 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
(Unaudited)
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Table of Contents
Note Page
1 Consolidated Financial Statements 15
2 Recent Accounting Guidance 16
3 Revenue 17
4 Divestitures 19
5 Restructuring and Asset Related Charges - Net 19
6 Supplementary Information 22
7 Income Taxes 23
8 Earnings Per Share Calculations 23
9 Inventories 24
10 Nonconsolidated Affiliates 24
11 Goodwill 25
12 Transfers of Financial Assets 25
13 Notes Payable, Long Term Debt and Available Credit Facilities 26
14 Commitments and Contingencies 28
15 Leases 31
16 Accumulated Other Comprehensive Loss 32
17 Noncontrolling Interests 33
18 Pension and Other Postretirement Benefit Plans 34
19 Stock-Based Compensation 34
20 Financial Instruments 35
21 Fair Value Measurements 39
22 Variable Interest Entities 40
23 Segments and Geographic Regions 41
NOTE 1 – CONSOLIDATED FINANCIAL STATEMENTS
Basis of Presentation
Dow Inc. is the direct parent company of The Dow Chemical Company and its consolidated subsidiaries ("TDCC"
and together with Dow Inc., "Dow" or the "Company"). The unaudited interim consolidated financial statements of
Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United
States of America ("GAAP") and reflect all adjustments (including normal recurring accruals) which, in the opinion of
management, are considered necessary for the fair presentation of the results for the periods presented. These
statements should be read in conjunction with the audited consolidated financial statements and notes thereto
included in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2024
("2024 10-K").
As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and considering that the financial
statements and disclosures of each company are substantially similar, the companies are filing a combined report
for this Quarterly Report on Form 10-Q. The information reflected in the report is equally applicable to both Dow Inc.
and TDCC, except where otherwise noted. Transactions between TDCC and Dow Inc. are treated as related party
transactions for TDCC.
Table of Contents
15
-- 15 of 73 --
Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation, a wholly
owned subsidiary of the Company. Additionally, the term "Diamond Infrastructure Solutions" means Dow InfraCo,
LLC, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S. Gulf Coast and
became a consolidated variable interest entity on May 1, 2025. See Notes 17 and 22 for additional information
about Diamond Infrastructure Solutions.
NOTE 2 – RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In the fourth quarter of 2024, the Company adopted the annual and interim disclosure requirements of Accounting
Standards Update ("ASU") 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment
Disclosures." The amendments expand a public business entity's segment disclosures by requiring disclosure of
significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), clarifying
when an entity may report one or more additional measures to assess segment performance, requiring enhanced
interim disclosures, providing new disclosure requirements for entities with a single reportable segment, and
requiring other new disclosures. See Note 23 for applicable reportable segment disclosures required by this
guidance.
Accounting Guidance Issued But Not Adopted at September 30, 2025
In December 2023, the Financial Accounting Standards Board ("FASB") issued ASU 2023-09, "Income Taxes
(Topic 740): Improvements to Income Tax Disclosures," which is intended to enhance the transparency, decision
usefulness and effectiveness of income tax disclosures. The amendments in this ASU require a public business
entity to disclose a tabular tax rate reconciliation, using both percentages and currency, with specific categories. A
public business entity is also required to provide a qualitative description of the states and local jurisdictions that
make up the majority of the effect of the state and local income tax category and the net amount of income taxes
paid, disaggregated by federal, state and foreign taxes and also disaggregated by individual jurisdictions. The
amendments also remove certain disclosures that are no longer considered cost beneficial. The amendments are
effective prospectively for annual periods beginning after December 15, 2024, and early adoption and retrospective
application are permitted. While the adoption of ASU 2023-09 will result in enhanced disclosures, the Company
does not expect it will have a material impact on its financial condition or results of operations.
In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—
Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses," which is
intended to improve disclosures about a public business entity's expenses and address requests from investors for
more detailed information about the types of expenses in commonly presented expense captions. Such information
should allow investors to better understand an entity's performance, assess future cash flows, and compare
performance over time and with other entities. The amendments will require public business entities to disclose in
the notes to the financial statements, at each interim and annual reporting period, specific information about certain
costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset
amortization included in each expense caption presented on the face of the income statement, and the total amount
of an entity's selling expenses. The amendments are effective for annual reporting periods beginning after
December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied either
prospectively or retrospectively. Early adoption is permitted. While the adoption of ASU 2024-03 will result in
enhanced disclosures, the Company does not expect it will have a material impact on its financial condition or
results of operations.
In September 2025, the FASB issued ASU 2025-06, "Intangibles—Goodwill and Other—Internal-Use Software
(Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software," which is intended to
modernize the accounting for the costs of internal-use software given the evolution of software development to the
incremental and iterative development method. The amendments remove all references to prescriptive and
sequential development stages and, instead, require an entity to start capitalizing software costs when management
has authorized and committed to funding the software project, and it is probable that the project will be completed
and the software will be used to perform the function intended. The amendments are effective for annual reporting
periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods.
Early adoption is permitted as of the beginning of an annual reporting period with the amendments to be applied
using a prospective, modified or retrospective transition approach. The Company is currently evaluating the impact
of adopting this guidance on the consolidated financial statements.
Table of Contents
16
-- 16 of 73 --
SEC Final Rules Not Adopted at September 30, 2025
In March 2024, the U.S. Securities and Exchange Commission ("SEC") adopted final rules under SEC Release Nos.
33-11275 and 34-99678, "The Enhancement and Standardization of Climate-Related Disclosures for Investors,"
which requires registrants to disclose certain climate-related information in registration statements and annual
reports. As a large accelerated filer, most disclosure requirements would be effective for the Company beginning in
the year ending December 31, 2025, with certain greenhouse gas emissions disclosures required for the year
ending December 31, 2026. In April 2024, the SEC issued an order to stay the final rules until various legal
challenges are resolved by the U.S. Court of Appeals for the Eighth Circuit ("Court of Appeals"). In March 2025, the
SEC voted to end its defense of the final rules and, in July 2025, the SEC asked the Court of Appeals to resolve the
merits of the challenge to the final rules. In September 2025, the Court of Appeals ordered the litigation to be held in
abeyance pending further action from the SEC.
NOTE 3 – REVENUE
Revenue Recognition
The majority of the Company's revenue is derived from product sales. The Company's revenue related to product
sales was 98 percent for the three and nine months ended September 30, 2025 (97 percent and 98 percent for the
three and nine months ended September 30, 2024, respectively). The remaining sales were primarily related to the
Company's insurance operations and licensing of patents and technologies. Product sales consist of sales of the
Company's products to manufacturers and distributors. The Company considers order confirmations or purchase
orders, which in some cases are governed by master supply agreements, to be contracts with a customer. The
Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to
customers. Revenue from the Company’s licenses for patents and technology is derived from sales-based royalties
and licensing arrangements based on billing schedules established in each contract.
Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied
performance obligations. At September 30, 2025, the Company had unfulfilled performance obligations of
$735 million ($759 million at December 31, 2024) related to the licensing of technology. The Company expects
revenue to be recognized for the remaining performance obligations over the next five years.
The Company has additional remaining performance obligations for product sales that have expected durations of
one year or less, product sales of materials delivered through a pipeline for which the Company has elected the
"right to invoice" practical expedient, and variable consideration attributable to royalties for licenses of patents and
technology. The Company has received advance payments from customers related to long-term supply agreements
that are deferred and recognized over the life of the contract, with remaining contract terms that range up
to 18 years. The Company will have rights to future consideration for revenue recognized when product is delivered
to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent
obligations" in the consolidated balance sheets.
Table of Contents
17
-- 17 of 73 --
Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by operating segment and business, as the
Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See
details in the tables below:
Net Trade Sales by Segment and Business Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Hydrocarbons & Energy $ 1,233 $ 1,433 $ 4,161 $ 4,347
Packaging and Specialty Plastics 3,658 4,083 11,065 12,114
Packaging & Specialty Plastics $ 4,891 $ 5,516 $ 15,226 $ 16,461
Industrial Solutions $ 1,004 $ 1,039 $ 3,043 $ 3,107
Polyurethanes & Construction Chemicals 1,826 1,919 5,420 5,805
Other 4 4 12 9
Industrial Intermediates & Infrastructure $ 2,834 $ 2,962 $ 8,475 $ 8,921
Coatings & Performance Monomers $ 809 $ 891 $ 2,518 $ 2,704
Consumer Solutions 1,273 1,323 3,764 3,905
Performance Materials & Coatings $ 2,082 $ 2,214 $ 6,282 $ 6,609
Corporate $ 166 $ 187 $ 525 $ 568
Total $ 9,973 $ 10,879 $ 30,508 $ 32,559
Net Trade Sales by Geographic Region Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
U.S. & Canada $ 3,914 $ 4,149 $ 12,129 $ 12,470
EMEAI 1 3,090 3,568 9,636 10,624
Asia Pacific 1,838 1,890 5,433 5,712
Latin America 1,131 1,272 3,310 3,753
Total $ 9,973 $ 10,879 $ 30,508 $ 32,559
1. Europe, Middle East, Africa and India.
Contract Assets and Liabilities
The Company receives payments from customers based upon contractual billing schedules. Accounts receivable
are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the
Company's contractual right to consideration for completed performance obligations not yet invoiced. Contract
liabilities include payments received in advance of performance under the contract and are recognized in revenue
when the performance obligations are met. "Contract liabilities - current" primarily reflects deferred revenue from
prepayments from customers for product to be delivered in 12 months or less and royalty payments that are
deferred and will be recognized in 12 months or less. "Contract liabilities - noncurrent" includes advance payments
that the Company has received from customers related to long-term supply agreements and royalty payments that
are deferred and recognized over the life of the contract.
Revenue recognized in the first nine months of 2025 from amounts included in contract liabilities at the beginning of
the period was approximately $170 million (approximately $135 million in the first nine months of 2024). In the first
nine months of 2025 and 2024, the amount of contract assets reclassified to receivables as a result of the right to
the transaction consideration becoming unconditional was insignificant.
Table of Contents
18
-- 18 of 73 --
The following table summarizes contract assets and liabilities at September 30, 2025 and December 31, 2024:
Contract Assets and Liabilities
Balance Sheet Classification Sep 30,
2025 Dec 31,
2024 In millions
Accounts and notes receivable - trade Accounts and notes receivable - trade $ 5,044 $ 4,756
Contract assets - noncurrent Deferred charges and other assets $ — $ 2
Contract liabilities - current Accrued and other current liabilities $ 220 $ 244
Contract liabilities - noncurrent 1 Other noncurrent obligations $ 1,791 $ 1,480
1. The increase from December 31, 2024 to September 30, 2025 was primarily due to advance payments on long-term supply agreements.
NOTE 4 – DIVESTITURES
Divestiture of Soil Fumigation Product Line
On May 1, 2025, the Company sold TeloneTM, a soil fumigation product line, and certain related assets to TriCal Soil
Solutions, Inc. ("TriCal"), a distributor and applicator of soil fumigation products, for cash proceeds of $121 million,
net of costs to sell and other transaction expenses and subject to customary post-closing adjustments. Under the
sale and purchase agreement, Dow retained ownership of the related production assets, which are leased to TriCal
as part of a toll manufacturing arrangement that directs the Company to manufacture and deliver certain products to
TriCal. These asset leases are classified as operating leases. Dow and TriCal have also entered into a site services
agreement related to certain services the Company will provide to TriCal at its site in Stade, Germany. Divested
assets included property with a net book value of $5 million and goodwill of $10 million. The Company recognized a
pretax gain of $103 million in the second quarter of 2025, included in "Sundry income (expense) - net" in the
consolidated statements of income and related to Industrial Intermediates & Infrastructure.
Divestiture of Investment in DowAksa
On August 8, 2025, the Company sold its ownership interest in DowAksa Advanced Composites Holdings BV
("DowAksa"), a nonconsolidated affiliate, to its joint venture partner, Aksa Akrilik Kimya Sanayii A.Ş., for cash
proceeds of $121 million, net of costs to sell and other transaction expenses and subject to customary post-closing
adjustments. The Company's investment balance in DowAksa was $11 million and the Company recognized a
pretax gain of $110 million in the third quarter of 2025, included in "Sundry income (expense) - net" in the
consolidated statements of income and related to Corporate.
The Company evaluated the divestitures of its soil fumigation product line and its investment in DowAksa and
determined they did not represent strategic shifts that had a major effect on the Company’s operations and financial
results and did not qualify as individually significant components of the Company. As a result, the divestitures are
not reported as discontinued operations.
NOTE 5 – RESTRUCTURING AND ASSET RELATED CHARGES - NET
Charges for restructuring programs and other asset related charges, which include asset impairments, are recorded
in "Restructuring and asset related charges - net" in the consolidated statements of income. For additional
information on the Company's 2023 Restructuring Program and other asset related charges, see Note 5 to the
Consolidated Financial Statements included in the 2024 10-K.
2025 Restructuring Program
On January 27, 2025, the Dow Inc. Board of Directors ("Board") approved targeted actions to further achieve the
Company's cost reduction initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-
term competitiveness across the economic cycle. The actions include a workforce reduction of approximately
1,500 roles. As a result of these actions, in the first quarter of 2025 the Company recorded pretax charges of
$207 million for severance and related benefits costs, included in "Restructuring and asset related charges - net" in
the consolidated statements of income, related to Corporate. These actions are expected to be substantially
complete by the end of 2026.
Table of Contents
19
-- 19 of 73 --
On June 30, 2025, the Board approved restructuring actions to rationalize the Company's global asset footprint,
including certain actions identified as part of the Company's previously announced strategic review of its European
assets and certain corporate and other assets, and to enhance the Company's competitiveness over the economic
cycle. The program includes asset write-down and write-off charges, severance and related benefit costs and other
exit and disposal costs. As a result of these actions, in the second quarter of 2025, the Company recorded pretax
restructuring charges of $591 million, consisting of severance and related benefit costs of $154 million, asset write-
downs and write-offs of $334 million and costs associated with exit and disposal activities of $103 million. In the
third quarter of 2025, the Company recorded additional pretax restructuring charges of $23 million, consisting of
asset write-downs and write-offs of $8 million and costs associated with exit and disposal activities of $15 million.
The impact of these charges is shown as "Restructuring and asset related charges - net" in the consolidated
statements of income. See Note 21 for additional information on nonrecurring fair value measurements. The
following table summarizes the activities related to the 2025 Restructuring Program, including segment information:
2025 Restructuring Program
Severance
and Related
Benefit Costs
Asset Write-
downs and
Write-offs
Costs
Associated
with Exit and
Disposal
Activities Total In millions
Corporate $ 207 $ — $ — $ 207
Total restructuring charges $ 207 $ — $ — $ 207
Reserve balance at Mar 31, 2025 $ 207 $ — $ — $ 207
Packaging & Specialty Plastics $ — $ 81 $ 77 $ 158
Industrial Intermediates & Infrastructure — 63 26 89
Performance Materials & Coatings — 147 — 147
Corporate 154 43 — 197
Total restructuring charges $ 154 $ 334 $ 103 $ 591
Charges against the reserve 1 — (334) (103) (437)
Cash payments (16) — — (16)
Reserve balance at Jun 30, 2025 $ 345 $ — $ — $ 345
Packaging & Specialty Plastics $ — $ 3 $ — $ 3
Industrial Intermediates & Infrastructure — 1 5 6
Performance Materials & Coatings — 3 — 3
Corporate — 1 10 11
Total restructuring charges $ — $ 8 $ 15 $ 23
Charges against the reserve 1 — (8) (15) (23)
Cash payments (66) — — (66)
Reserve balance at Sep 30, 2025 $ 279 $ — $ — $ 279
1. Costs associated with exit and disposal activities relate to asset retirement obligations and pension benefit settlement costs.
At September 30, 2025, $141 million of the restructuring reserve balance was included in "Accrued and other
current liabilities" and $138 million was included in "Other noncurrent obligations" in the consolidated balance
sheets.
The Company recorded pretax restructuring charges of $821 million inception-to-date under the 2025 Restructuring
Program, consisting of severance and related benefit costs of $361 million, asset write-downs and write-offs of
$342 million and costs associated with exit and disposal activities of $118 million.
Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions
and costs associated with the Company's restructuring actions, are expected to result in additional cash
expenditures of approximately $220 million. Restructuring implementation costs totaled $5 million and $10 million
for the three and nine months ended September 30, 2025, respectively.
Table of Contents
20
-- 20 of 73 --
Severance and Related Benefit Costs
Severance benefits are provided to employees primarily under Dow's ongoing benefit arrangements and are
accrued against the Corporate segment once management commits to a plan of termination. The 2025
Restructuring Program included charges for severance and related benefit costs of $361 million. At September 30,
2025, $82 million in severance payments had been made.
Asset Write-downs and Write-offs
The 2025 Restructuring Program included charges related to the write-down and write-off of assets totaling
$342 million. Details regarding the asset write-downs and write-offs are as follows:
• Packaging & Specialty Plastics recorded a charge to rationalize its global asset footprint by shutting down
an ethylene facility in Böhlen, Germany by the end of 2027.
• Industrial Intermediates & Infrastructure recorded a charge to primarily rationalize its global asset footprint
by shutting down certain chlor-alkali and vinyl assets in Schkopau, Germany by the end of 2027.
• Performance Materials & Coatings recorded a charge to primarily rationalize its global asset footprint by
shutting down a basics siloxanes plant in Barry, United Kingdom by mid-year 2026.
• Corporate recorded charges related to the write-down of certain Company owned and leased non-
manufacturing facilities and other assets.
Costs Associated with Exit and Disposal Activities
In the first nine months of 2025, the Company accrued additional asset retirement obligations of $105 million and
wrote off related deferred asset charges associated with the asset shutdowns noted above, resulting in charges of
$103 million and $5 million in the second and third quarters of 2025, respectively. See Note 14 for additional
information related to the Company’s asset retirement obligations.
The 2025 Restructuring Program also included a pretax charge of $10 million for net pension benefit settlement
costs related to participants of a pension plan in Europe that were impacted by the restructuring program, recorded
in the third quarter of 2025.
It is reasonably possible the Company will incur approximately $60 million of future charges related to costs
associated with exit and disposal activities.
In addition, the Company is assessing potential environmental remediation activities associated with the asset
actions noted above, which could result in additional charges and cash payments in the future. The Company
intends to continue operating other assets at the sites impacted by these actions.
2023 Restructuring Program
Actions related to the restructuring program approved by the Board on January 25, 2023, were complete at the end
of the second quarter of 2025. In the first quarter of 2025, the Company recorded an additional pretax restructuring
charge of $5 million for asset write-downs and write-offs and an asset related credit adjustment of $4 million,
included in "Restructuring and asset related charges - net" in the consolidated statements of income, related to
Industrial Intermediates & Infrastructure. See Note 21 for additional information on nonrecurring fair value
measurements. Restructuring implementation and efficiency costs were zero and $50 million for the three and nine
months ended September 30, 2025, respectively ($55 million and $157 million for the three and nine months ended
September 30, 2024, respectively).
Table of Contents
21
-- 21 of 73 --
NOTE 6 – SUPPLEMENTARY INFORMATION
Dow Inc. Sundry Income (Expense) – Net Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Non-operating pension and other postretirement benefit plan net
credits 1 $ 36 $ 61 $ 110 $ 183
Foreign exchange gains (losses) 2 12 (14) 23 (49)
Gain on sales of other assets and investments 3 5 27 — 46
Gain on divestiture of ownership interest in DowAksa 4 110 — 110 —
Gain on divestiture of soil fumigation product line 4 — — 103 —
Gain (loss) on early extinguishment of debt 5 (18) — (78) 5
Indemnification and other transaction related costs 6 (3) 1 (20) 2
Other - net 43 44 97 69
Total sundry income (expense) – net $ 185 $ 119 $ 345 $ 256
1. See Note 18 for additional information.
2. Foreign exchange gains for the three and nine months ended September 30, 2025 relate primarily to exposures to the Euro, partially offset by
losses in exposures to the Argentine peso. Foreign exchange losses for the three months ended September 30, 2024 relate primarily to
exposures in the Argentine peso, while losses in the nine months ended September 30, 2024 relate primarily to exposures in the Egyptian
pound and Argentine peso.
3. The three and nine months ended September 30, 2024 include a gain of $25 million associated with a warehouse sale.
4. See Note 4 for additional information.
5. See Note 13 for additional information.
6. Primarily related to charges associated with agreements entered into with DuPont de Nemours, Inc. ("DuPont") and Corteva, Inc. ("Corteva")
as part of the separation and distribution.
Sundry income (expense) - net for TDCC for the three and nine months ended September 30, 2025 and 2024 is
substantially the same as that of Dow Inc. and, therefore, Sundry income (expense) - net for TDCC is not disclosed
separately.
Other Investments
The Company has investments in company-owned life insurance policies, which are recorded at their cash
surrender value as of each balance sheet date, as provided below:
Investments in Company-Owned Life Insurance Sep 30,
2025 Dec 31,
2024 In millions
Gross cash value $ 515 $ 558
Less: Existing drawdowns 1 197 —
Less: Accrued interest on drawdowns 2 5 —
Investments in company-owned life insurance 3 $ 313 $ 558
1. Classified as "Proceeds from sales and maturities of investments" in the consolidated statements of cash flows.
2. Included in "Sundry income (expense) - net" in the consolidated statements of income.
3. Classified as "Other investments" in the consolidated balance sheets.
Supplier Finance Program
The Company facilitates a supply chain financing (“SCF”) program in the ordinary course of business in order to
extend payment terms with vendors. Under the terms of this program, a vendor can voluntarily enter into an
agreement with a participating financial intermediary to sell its receivables due from the Company. The vendor
receives payment from the financial intermediary, and the Company pays the financial intermediary on the terms
originally negotiated with the vendor, which generally range from 90 to 120 days. The vendor negotiates the terms
of the agreements directly with the financial intermediary and the Company is not a party to that agreement.
The financial intermediary may allow the participating vendor to utilize the Company’s creditworthiness in
establishing credit spreads and associated costs, which may provide the vendor with more favorable terms than
they would be able to secure on their own. The Company does not provide guarantees related to the SCF program.
At September 30, 2025, outstanding obligations confirmed as valid under the SCF program were $288 million
($291 million at December 31, 2024), included in “Accounts payable – Trade” in the consolidated balance sheets.
Table of Contents
22
-- 22 of 73 --
NOTE 7 – INCOME TAXES
As the financial statements for Dow Inc. and TDCC are substantially similar, including the provision (credit) for
income taxes, the following income tax discussion does not include reference to TDCC's provision (credit) for
income taxes or its effective tax rate.
The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of
income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity
method investments are taxed at the joint venture level.
The following table provides effective tax rate information for Dow Inc. for the three and nine months ended
September 30, 2025 and 2024:
Effective Tax Rate Information Three Months Ended Nine Months Ended
Amounts in millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Income (loss) before income taxes $ 70 $ 324 $ (963) $ 1,381
Provision (credit) for income taxes $ (54) $ 84 $ 4 $ 145
Effective tax rate (77.1) % 25.9 % (0.4) % 10.5 %
The credit for income taxes for the three months ended September 30, 2025 was impacted by the recording of a tax
benefit stemming from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner of
$100 million and a tax benefit of $20 million related to the sale of an additional portion of the Company's
membership interests in Diamond Infrastructure Solutions, partially offset by losses attributable to jurisdictions for
which no tax benefit can be recognized. The provision for income taxes for the nine months ended September 30,
2025 was also impacted by the initial sale of a portion of the Company's membership interests in Diamond
Infrastructure Solutions resulting in a tax benefit of $89 million, which was offset by valuation allowances in certain
foreign jurisdictions of $242 million. See Note 17 for additional information related to the Diamond Infrastructure
Solutions transaction.
In the first nine months of 2024, the Company recorded a tax benefit of $194 million related to a reassessment of
interest and penalties on a tax matter in a foreign jurisdiction, resulting in a reduced effective tax rate for the period.
On July 4, 2025, U.S. legislation formally titled "An Act to Provide for Reconciliation Pursuant to Title II of H. Con.
Res. 14” (“the Act”) and commonly referred to as the One Big Beautiful Bill Act was signed into law. The Act, among
other things, extended key provisions of the 2017 Tax Cuts and Jobs Act and introduced targeted changes to the
U.S. federal income tax regime. Based on the analysis performed by the Company to date, the Act is not expected
to have a material impact on the effective tax rate.
NOTE 8 – EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations for Dow Inc. for the three and nine months ended
September 30, 2025 and 2024. Earnings per share of TDCC is not presented as this information is not required in
financial statements of wholly owned subsidiaries.
Net Income (Loss) for Earnings Per Share Calculations Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net income (loss) $ 124 $ 240 $ (967) $ 1,236
Net income attributable to noncontrolling interests 62 26 113 67
Net income attributable to participating securities 1 2 3 9 9
Net income (loss) attributable to common stockholders $ 60 $ 211 $ (1,089) $ 1,160
1. Restricted stock units are considered participating securities due to the Company's practice of paying dividend equivalents on unvested
shares.
Table of Contents
23
-- 23 of 73 --
Earnings (Loss) Per Share - Basic and Diluted Three Months Ended Nine Months Ended
Dollars per share
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Earnings (loss) per common share - basic $ 0.08 $ 0.30 $ (1.53) $ 1.65
Earnings (loss) per common share - diluted $ 0.08 $ 0.30 $ (1.53) $ 1.65
Share Count Information Three Months Ended Nine Months Ended
Shares in millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Weighted-average common shares outstanding - basic 711.8 702.3 709.4 703.5
Plus dilutive effect of equity compensation plans 1 1.4 1.3 — 1.4
Weighted-average common shares outstanding - diluted 713.2 703.6 709.4 704.9
Stock units excluded from EPS calculations 2 19.3 10.5 23.6 9.6
1. The nine months ended September 30, 2025 reflect a net loss and, as such, the basic share count was used for purposes of calculating
earnings per share on a diluted basis.
2. These outstanding stock units were excluded from the calculation of diluted earnings per share because the effect of including them would
have been antidilutive.
NOTE 9 – INVENTORIES
The following table provides a breakdown of inventories:
Inventories Sep 30,
2025 Dec 31,
2024 In millions
Finished goods $ 3,709 $ 3,773
Work in process 1,300 1,323
Raw materials 839 822
Supplies 1,176 1,039
Total $ 7,024 $ 6,957
Adjustment of inventories to the LIFO basis (349) (413)
Total inventories $ 6,675 $ 6,544
NOTE 10 – NONCONSOLIDATED AFFILIATES
For additional information on the Company’s nonconsolidated affiliates, see Note 11 to the Consolidated Financial
Statements included in the 2024 10-K.
The Company's investments in companies accounted for using the equity method ("nonconsolidated affiliates"), by
classification in the consolidated balance sheets are shown in the following table:
Investments in Nonconsolidated Affiliates Sep 30,
2025 Dec 31,
2024 In millions
Investment in nonconsolidated affiliates $ 1,255 $ 1,266
Other noncurrent obligations (892) (568)
Net investment in nonconsolidated affiliates $ 363 $ 698
At September 30, 2025, the Company had a negative investment balance in Sadara Chemical Company of
$851 million included in "Other noncurrent obligations" (negative $517 million at December 31, 2024) in the
consolidated balance sheets. The increased negative investment in Sadara Chemical Company at September 30,
2025 is due to equity losses generated during the first nine months of 2025 driven by the impact of challenging
macroeconomic conditions.
Table of Contents
24
-- 24 of 73 --
At September 30, 2025, the Company had a negative investment balance in EQUATE Petrochemical Company
K.S.C.C of $41 million included in "Other noncurrent obligations" (negative $51 million at December 31, 2024) in the
consolidated balance sheets. The decrease in the negative investment was driven by equity earnings, partially offset
by dividends distributed to shareholders in the first nine months of 2025.
NOTE 11 – GOODWILL
The following table shows changes in the carrying amount of goodwill by reportable segment:
Goodwill Packaging &
Specialty Plastics
Industrial
Intermediates &
Infrastructure
Performance
Materials &
Coatings Total In millions
Net goodwill at Dec 31, 2024 $ 5,118 $ 1,092 $ 2,355 $ 8,565
Divestiture — (10) — (10)
Foreign currency impact 13 5 117 135
Net goodwill at Sep 30, 2025 $ 5,131 $ 1,087 $ 2,472 $ 8,690
Goodwill Impairment Testing
In the second quarter of 2025, the Company identified potential indicators of goodwill impairment due to announced
restructuring actions and ongoing macroeconomic challenges. As a result, the Company evaluated whether the fair
value of any reporting unit may be less than its carrying amount. This assessment indicated that the Consumer
Solutions reporting unit, part of the Performance Materials & Coatings segment, required an interim quantitative
goodwill impairment test as of June 30, 2025. The test concluded that no goodwill impairment existed, as the fair
value of the Consumer Solutions reporting unit exceeded its carrying value. Fair value was estimated using a
discounted cash flow model that incorporated current market conditions and the anticipated effects of the
restructuring actions. Key assumptions included projected revenue growth, discount rate, tax rate, terminal value,
currency exchange rates, and long-term raw material and energy price forecasts.
In the third quarter of 2025, as a result of continued macroeconomic challenges, the Company evaluated whether
the fair value of any reporting unit may be less than its carrying amount. This assessment indicated that the
Packaging and Specialty Plastics reporting unit, part of the Packaging & Specialty Plastics segment, required an
interim quantitative goodwill impairment test as of September 30, 2025. The test concluded that no goodwill
impairment existed, as the fair value of the Packaging and Specialty Plastics reporting unit exceeded its carrying
value. Fair value was estimated using a discounted cash flow model that incorporated current market conditions.
Key assumptions included projected revenue growth, discount rate, tax rate, terminal value, currency exchange
rates, and long-term raw material and energy price forecasts.
The Company continues to monitor key factors that could impact the fair value of its reporting units, including
changes in macroeconomic conditions or industry-specific trends, deterioration in financial performance, increases
in market interest rates or adverse changes in regulatory or competitive environments. If these or other adverse
events occur, it may be necessary to perform additional impairment testing, which could result in a future goodwill
impairment charge.
NOTE 12 – TRANSFERS OF FINANCIAL ASSETS
Accounts Receivable Programs
The Company maintains accounts receivable facilities with various financial institutions, with committed and
uncommitted facilities in the United States and a committed facility in Europe (collectively, "the Programs"), which
are set to expire in November 2025 and are expected to be renewed in the fourth quarter. Under the terms of the
Programs, the Company may sell certain eligible trade accounts receivable at any point in time, up to $900 million
for the U.S. committed facility and up to €500 million for the Europe committed facility. Under the terms of the
Programs, the Company continues to service the receivables from the customer, but retains no interest in the
receivables, and remits payment to the financial institutions. Losses on transfers of receivables were insignificant for
the three and nine months ended September 30, 2025 and 2024. The Company also provides a guarantee to the
financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See
Note 14 for additional information related to guarantees.
Table of Contents
25
-- 25 of 73 --
The Company has access to accounts receivable discounting facilities that cover certain receivables generated from
sales in EMEAI, Asia Pacific and Canada (collectively, "the Facilities"). Under the terms of the Facilities, the
Company retains no interest in the transferred receivables once sold and receivables are transferred with limited
recourse. The Company continues to service the receivables from the customer and remits payment to the
Facilities. Losses on transfers of receivables were insignificant for the three and nine months ended September 30,
2025 and 2024.
The following table provides a summary of cash flows related to the Programs and the Facilities for the three and
nine months ended September 30, 2025 and 2024:
Cash Flows Related to Transfers of Accounts Receivable Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Proceeds received from new transfers $ — $ 198 $ 538 $ 1,248
The following table provides the balances related to the Programs and the Facilities at September 30, 2025 and
December 31, 2024:
Balances Related to Transfers of Accounts Receivable Sep 30,
2025 Dec 31,
2024 In millions
Balance outstanding $ 6 $ 287
Accounts receivable derecognized $ — $ 278
Amounts recognized in the consolidated balance sheets:
Accrued and other current liabilities 1 $ 6 $ 9
1. Represents amounts collected from customers and not yet remitted by the Company.
NOTE 13 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES
Notes Payable Sep 30,
2025 Dec 31,
2024 In millions
Notes payable to banks and other lenders $ 133 $ 135
Period-end average interest rates 40.08 % 36.03 %
Long-Term Debt 2025
Average
Rate Sep 30,
2025
2024
Average
Rate Dec 31,
2024 In millions
Promissory notes and debentures:
Final maturity 2025 4.55 % $ 208 5.63 % $ 333
Final maturity 2028 4.80 % 600 4.80 % 600
Final maturity 2029 1 7.53 % 951 7.58 % 1,368
Final maturity 2030 2.10 % 818 2.10 % 818
Final maturity 2031 and thereafter 1 5.41 % 11,561 5.37 % 9,192
Other facilities:
Foreign currency notes and loans, various rates and maturities 1 2.56 % 2,244 2.01 % 2,540
InterNotes®, varying maturities through 2053 4.71 % 891 4.31 % 661
Medium-term notes, maturity 2025 4.75 % 1 4.75 % 1
Finance lease obligations 2 1,079 939
Unamortized debt discount and issuance costs (231) (244)
Long-term debt due within one year 3 (413) (497)
Long-term debt $ 17,709 $ 15,711
1. Cost includes net fair value hedge adjustment gains of $35 million at September 30, 2025 ($9 million at December 31, 2024). See Note 20 for
additional information.
2. See Note 15 for additional information.
3. Presented net of current portion of unamortized debt issuance costs.
Table of Contents
26
-- 26 of 73 --
Maturities of Long-Term Debt for Next Five Years at Sep 30, 2025
In millions
2025 $ 245
2026 $ 207
2027 $ 782
2028 $ 750
2029 $ 1,061
2030 $ 996
2025 Activity
In the first quarter of 2025, the Company completed debt neutral liability management activities. The Company
issued $1 billion of senior unsecured notes. The offering included $400 million aggregate principal amount of
5.35 percent notes due 2035 and $600 million aggregate principal amount of 5.95 percent notes due 2055. The
Company used the proceeds to complete cash tender offers for certain debt securities. In total, $943 million
aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of
$60 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated
statements of income, related to Corporate.
In the third quarter of 2025, the Company issued $1.4 billion of senior unsecured notes. The offering included
$750 million aggregate principal amount of 4.80 percent notes due 2031 and $650 million aggregate principal
amount of 5.65 percent notes due 2036. Additionally, the Company redeemed $55 million aggregate principal
amount of 9.40 percent notes due 2039. As a result of the redemption, the Company recognized a pretax loss of
$18 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated
statements of income, related to Corporate.
In the first nine months of 2025, the Company issued an aggregate principal amount of $252 million of InterNotes®.
Additionally, the Company repaid $125 million of long-term debt at maturity.
Available Credit Facilities
The following table summarizes the Company's credit facilities:
Committed and Available Credit Facilities at Sep 30, 2025
In millions
Committed
Credit Available
Credit Maturity Date Interest
Five Year Competitive Advance and Revolving Credit
Facility $ 5,000 $ 5,000 June 2030 Floating rate
Bilateral Revolving Credit Facility 300 300 November 2025 Floating rate
Bilateral Revolving Credit Facility 300 300 February 2026 Floating rate
Bilateral Revolving Credit Facility 100 100 March 2026 Floating rate
Bilateral Revolving Credit Facility 375 375 October 2026 Floating rate
Bilateral Revolving Credit Facility 150 150 November 2026 Floating rate
Bilateral Revolving Credit Facility 200 200 November 2026 Floating rate
Bilateral Revolving Credit Facility 250 250 March 2027 Floating rate
Bilateral Revolving Credit Facility 100 100 May 2027 Floating rate
Bilateral Revolving Credit Facility 350 350 June 2027 Floating rate
Bilateral Revolving Credit Facility 200 200 September 2027 Floating rate
Bilateral Revolving Credit Facility 100 100 October 2027 Floating rate
Bilateral Revolving Credit Facility 100 100 March 2028 Floating rate
Bilateral Revolving Credit Facility 100 100 March 2028 Floating rate
Bilateral Revolving Credit Facility 300 300 May 2028 Floating rate
Bilateral Revolving Credit Facility 200 200 September 2028 Floating rate
Bilateral Revolving Credit Facility 175 175 September 2028 Floating rate
Bilateral Revolving Credit Facility 100 100 June 2030 Floating rate
Total committed and available credit facilities $ 8,400 $ 8,400
Table of Contents
27
-- 27 of 73 --
Debt Covenants and Default Provisions
There were no material changes to the debt covenants and default provisions related to the Company's outstanding
long-term debt and primary, private credit agreements in the first nine months of 2025. For additional information on
the Company's debt covenants and default provisions, see Note 14 to the Consolidated Financial Statements
included in the 2024 10-K.
NOTE 14 – COMMITMENTS AND CONTINGENCIES
A summary of the Company's commitments and contingencies can be found in Note 15 to the Consolidated
Financial Statements included in the 2024 10-K, which is incorporated by reference herein.
Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the
amount of the liability can be reasonably estimated, based on current law and existing technologies. At
September 30, 2025, the Company had accrued obligations of $1,044 million for probable environmental
remediation and restoration costs ($1,113 million at December 31, 2024), including $220 million for the remediation
of Superfund sites ($234 million at December 31, 2024). This is management’s best estimate of the costs for
remediation and restoration with respect to environmental matters for which the Company has accrued liabilities,
although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to
approximately two times that amount. Consequently, it is reasonably possible that environmental remediation and
restoration costs in excess of amounts accrued could have a material impact on the Company's results of
operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the
possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s
results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due
to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging
remediation technologies for handling site remediation and restoration. As new or additional information becomes
available and/or certain spending trends become known, management will evaluate such information in
determination of the current estimate of environmental liability.
Litigation
Asbestos-Related Matters of Union Carbide Corporation
Each quarter, Union Carbide reviews asbestos-related claims filed, settled and dismissed, as well as average
settlement and resolution costs by disease category. Union Carbide also considers additional quantitative and
qualitative factors such as the nature of pending claims, trial experience of Union Carbide and other asbestos
defendants, current spending for defense and processing costs, significant appellate rulings and legislative
developments, trends in the tort system, and their respective effects on expected future resolution costs. Union
Carbide's management considers these factors in conjunction with the most recent actuarial study and determines
whether a change in the estimate is warranted. Based on Union Carbide's review of 2025 activity, it was determined
that no adjustment to the accrual was required at September 30, 2025.
Union Carbide’s total asbestos-related liability for pending and future claims and defense and processing costs was
$726 million at September 30, 2025 ($791 million at December 31, 2024). At September 30, 2025, approximately
26 percent of the recorded claim liability related to pending claims and approximately 74 percent related to future
claims.
Legacy Matters
Groundwater Matters
The Company is the subject of various complaints related to alleged groundwater contamination based on decades-
old sales and applications of certain agricultural chemical products ("Groundwater Matters"). The costs associated
with these Groundwater Matters were previously covered by insurance policies that have since been depleted. In
the first quarter of 2023, the Company completed a study of certain Groundwater Matters related to wells deemed to
be probable and estimable based on the public reporting of sampling data and historical information to develop a
reasonable estimate of the cost of pending and future claims and accrued a charge based on the estimate. In the
second quarter of 2025, the Company completed a reassessment study of these Groundwater Matters based on
current known factors, resulting in a reduced estimate of the cost of pending and future claims. As a result, the
Company recorded a pretax credit of $106 million, included in "Cost of sales" in the consolidated statements of
income and related to Corporate. In the second quarter of 2025, the Company settled a separate claim related to
Groundwater Matters at a water storage district, resulting in a pretax charge of $64 million, included in "Cost of
sales" in the consolidated statements of income and related to Corporate.
Table of Contents
28
-- 28 of 73 --
At September 30, 2025, the total liability related to settled claims and the probable and estimable settlement of all
alleged Groundwater Matters was $78 million ($155 million at December 31, 2024), which was included in “Accrued
and other current liabilities” and "Other noncurrent obligations" in the consolidated balance sheets.
The Company is also the subject of other groundwater contamination complaints, including claims related to 1,4-
dioxane. The Company continues to defend itself in this litigation and has determined that the Company's exposure
to liability, if any, is not probable or estimable at September 30, 2025.
Other Legacy Matters
On October 10, 2024, the Company executed a settlement agreement related to arbitration for historical product
claims from a divested business. As a result, the Company recorded a pretax charge of $75 million in the third
quarter of 2024, which was paid in the fourth quarter of 2024. Arbitration on the matter was concluded on March 11,
2025, and, as a result, the Company recorded an additional pretax charge of $98 million in the first quarter of 2025,
which is included in "Cost of sales" in the consolidated statements of income, related to Corporate, and was paid in
the second quarter of 2025.
Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter
In 2019, the Court of King's Bench of Alberta, Canada ("Court") found Nova Chemicals Corporation ("Nova") liable
for engaging in a deliberate and continuing course of conduct of conversion, breach of contract, gross negligence
and willful misconduct in the operation of the companies’ jointly-owned ethylene asset in Joffre, Alberta, Canada. As
a result of the liability finding, which is now final and non-appealable, the Court signed a judgment ordering Nova to
pay $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars) for damages incurred
through 2012. Nova made payment in October 2019. At September 30, 2025, $201 million ($201 million at
December 31, 2024) was included in "Other noncurrent obligations" in the Company's consolidated balance sheets
related to the disputed portion of the damages judgment.
Following an appeal, on June 10, 2025, the Court signed a separate judgment ordering Nova to pay an additional
amount of $1.62 billion Canadian dollars (equivalent to approximately $1.2 billion U.S. dollars) for damages incurred
through June 2018, which had not been previously quantified. The Court again found that Nova failed to operate the
companies' jointly-owned ethylene asset at full capacity during this time, depriving the Company’s subsidiaries of
millions of pounds of ethylene. On August 11, 2025, the Court also awarded fees of approximately $100 million U.S.
dollars, bringing Nova’s current payment obligation to approximately $1.3 billion U.S. dollars. While those awards
are subject to appeal, Alberta law requires Nova to satisfy the Court’s judgment in full notwithstanding its appeal in
order to avoid enforcement measures during the appeal process. Nova has since requested that the Court of Appeal
of Alberta stay the execution of the judgment pending its appeal. Nova’s request departs from well-established
Alberta law, and would require Nova to show, among other things, that it would be irreparably harmed by making the
required payment. Nova’s request for a stay has been fully briefed and argued, and a decision is expected by year-
end 2025. It is the Company’s position that Nova cannot meet the legal standard necessary to receive a stay and
avoid payment pending its appeal. We expect a decision on the stay from the Court of Appeal of Alberta by year-end
2025. If the Court of Appeal of Alberta grants the stay, Nova will not be required to pay the judgment to the
Company while the appeal process is ongoing.
Guarantees
The following table provides a summary of the final expiration, maximum future payments and recorded liability
included in the consolidated balance sheets for guarantees:
Guarantees Sep 30, 2025 Dec 31, 2024
In millions
Final
Expiration
Maximum
Future
Payments Recorded
Liability Final
Expiration
Maximum
Future
Payments Recorded
Liability
Guarantees 2038 $ 1,223 $ 138 2038 $ 1,456 $ 155
Table of Contents
29
-- 29 of 73 --
Guarantees arise during the ordinary course of business from relationships with customers, accounts receivable
facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance
of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as
commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company
to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of
nonconsolidated affiliates, which have expiration dates ranging from less than one year to 13 years. The Company’s
current expectation is that future payment or performance related to the non-performance of others is considered
remote.
The Company maintains accounts receivable facilities with various financial institutions, with committed and
uncommitted facilities in the United States and a committed facility in Europe. Under the terms of the Programs, the
Company continues to service the receivables from the customers, but retains no interest in the receivables, and
remits payment to the financial institutions. The Company also has access to accounts receivable discounting
facilities, under which receivables are transferred with limited recourse. The Company’s maximum guaranteed
liability for the accounts receivable facilities is zero at September 30, 2025 ($239 million at December 31, 2024).
TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an
agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In
conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s
debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace
period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by
TDCC in proportion to the Company’s 35 percent ownership interest. The Company does not expect to be required
to perform under the guarantees. As part of the debt re-profiling, Sadara established a $500 million revolving credit
facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the
grace period.
Asset Retirement Obligations
Asset retirement obligations are recorded as incurred and reasonably estimable, including obligations for which the
timing and/or method of settlement are conditional on a future event that may or may not be within the control of the
Company. The retirement of assets may involve such efforts as remediation and treatment of asbestos,
contractually required demolition, and other related activities, depending on the nature and location of the assets;
and retirement obligations are typically realized only upon demolition of those facilities. As a result of the asset
shutdowns included in the restructuring activities discussed in Note 5, the Company accrued additional asset
retirement obligations of $105 million in the first nine months of 2025. At September 30, 2025, the aggregate
carrying amount of the Company's asset retirement obligations was $306 million ($174 million at December 31,
2024), which was included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the
consolidated balance sheets.
Table of Contents
30
-- 30 of 73 --
NOTE 15 – LEASES
For additional information on the Company's leases, see Note 16 to the Consolidated Financial Statements included
in the 2024 10-K.
The components of lease cost for operating and finance leases for the three and nine months ended September 30,
2025 and 2024 were as follows:
Lease Cost Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Operating lease cost $ 104 $ 112 $ 319 $ 329
Finance lease cost
Amortization of right-of-use assets - finance 33 31 97 86
Interest on lease liabilities - finance 13 11 37 33
Total finance lease cost 46 42 134 119
Short-term lease cost 77 80 244 242
Variable lease cost 304 280 842 803
Sublease income (3) (2) (6) (7)
Total lease cost $ 528 $ 512 $ 1,533 $ 1,486
The following table provides supplemental cash flow and other information related to leases:
Other Lease Information Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases $ 329 $ 334
Operating cash flows for finance leases $ 37 $ 33
Financing cash flows for finance leases $ 83 $ 95
Right-of-use assets obtained in exchange for lease obligations:
Operating leases $ 262 $ 186
Finance leases $ 202 $ 183
Table of Contents
31
-- 31 of 73 --
NOTE 16 – ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in each component of accumulated other comprehensive loss ("AOCL") for the three and nine months
ended September 30, 2025 and 2024 were as follows:
Accumulated Other Comprehensive Loss Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Unrealized Gains (Losses) on Investments
Beginning balance $ (233) $ (198) $ (243) $ (253)
Unrealized gains (losses) on investments 63 59 78 139
Tax (expense) benefit (8) (15) (13) (35)
Net unrealized gains (losses) on investments 55 44 65 104
(Gains) losses reclassified from AOCL to net income (loss) 1 3 (12) 3 (19)
Tax expense (benefit) 2 (1) 2 (1) 4
Net (gains) losses reclassified from AOCL to net income (loss) 2 (10) 2 (15)
Other comprehensive income (loss), net of tax 57 34 67 89
Ending balance $ (176) $ (164) $ (176) $ (164)
Cumulative Translation Adjustments
Beginning balance $ (1,812) $ (2,056) $ (2,063) $ (1,891)
Gains (losses) on foreign currency translation (69) 197 186 42
Tax (expense) benefit 47 8 62 5
Net gains (losses) on foreign currency translation (22) 205 248 47
(Gains) losses reclassified from AOCL to net income (loss) 3 (11) (6) (30) (13)
Other comprehensive income (loss), net of tax (33) 199 218 34
Ending balance $ (1,845) $ (1,857) $ (1,845) $ (1,857)
Pension and Other Postretirement Benefit Plans
Beginning balance $ (5,679) $ (5,452) $ (5,720) $ (5,486)
Gains (losses) arising during the period (1) 2 — 2
Amortization of net loss and prior service credits reclassified from
AOCL to net income (loss) 4 36 21 88 64
Tax expense (benefit) 2 (7) (5) (19) (14)
Net loss and prior service credits reclassified from AOCL to net
income (loss) 29 16 69 50
Other comprehensive income (loss), net of tax 28 18 69 52
Ending balance $ (5,651) $ (5,434) $ (5,651) $ (5,434)
Derivative Instruments
Beginning balance $ (102) $ (79) $ (84) $ (51)
Gains (losses) on derivative instruments (4) 37 (13) (9)
Tax (expense) benefit 2 (9) (4) 2
Net gains (losses) on derivative instruments (2) 28 (17) (7)
(Gains) losses reclassified from AOCL to net income (loss) 5 17 4 14 13
Tax expense (benefit) 2 (4) (1) (4) (3)
Net (gains) losses reclassified from AOCL to net income (loss) 13 3 10 10
Other comprehensive income (loss), net of tax 11 31 (7) 3
Ending balance $ (91) $ (48) $ (91) $ (48)
Total AOCL ending balance $ (7,763) $ (7,503) $ (7,763) $ (7,503)
1. Reclassified to "Net sales" and "Sundry income (expense) - net."
2. Reclassified to "Provision (credit) for income taxes."
3. Reclassified to "Sundry income (expense) - net."
4. These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and
other postretirement benefit plans. See Note 18 for additional information.
5. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
Table of Contents
32
-- 32 of 73 --
NOTE 17 – NONCONTROLLING INTERESTS
Ownership interests in the Company's subsidiaries held by parties other than the Company are presented
separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount
of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the
face of the consolidated statements of income.
On May 1, 2025, TDCC sold 40 percent of the membership interests in Diamond Infrastructure Solutions to
InfraPark Holdings, LLC ("InfraPark"), a subsidiary of a fund managed by Macquarie Asset Management, a global
infrastructure and energy asset manager, in exchange for cash proceeds of approximately $2.4 billion, inclusive of
customary post-closing adjustments. On August 29, 2025, as provided under the terms of the sale and purchase
agreement, InfraPark exercised its option to purchase an additional 9 percent of Diamond Infrastructure Solutions'
membership interests in exchange for proceeds of approximately $540 million. Diamond Infrastructure Solutions
and its subsidiaries own and operate certain non-product producing energy, environmental, pipeline and other
related infrastructure assets located at five of the Company's manufacturing sites on the U.S. Gulf Coast and
provide infrastructure services to Dow manufacturing assets and other third-party tenants at these locations.
InfraPark's ownership is accounted for as a noncontrolling interest in Diamond Infrastructure Solutions.
Cash proceeds from the sale of membership interests are included in "Proceeds from sale of noncontrolling
interests" in the consolidated statements of cash flows. The transactions resulted in an increase in "Additional paid-
in capital" of $339 million and $1,879 million and an increase in "Noncontrolling interests" of $194 million and
$1,028 million for the three and nine months ended September 30, 2025, respectively, recorded in the consolidated
balance sheets and the consolidated statements of equity.
The following table summarizes the activity for equity attributable to noncontrolling interests for the three and nine
months ended September 30, 2025 and 2024:
Noncontrolling Interests Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Balance at beginning of period $ 1,361 $ 482 $ 496 $ 501
Net income attributable to noncontrolling interests 62 26 113 67
Distributions to noncontrolling interests 1 (89) (2) (137) (41)
Cumulative translation adjustments (5) 24 23 4
Sale of noncontrolling interests 194 — 1,028 —
Other — — — (1)
Balance at end of period $ 1,523 $ 530 $ 1,523 $ 530
1. Includes dividends paid to a joint venture of zero and $8 million for the three and nine months ended September 30, 2025 ($8 million for the
three and nine months ended September 30, 2024) which were reclassified to "Equity in earnings (losses) of nonconsolidated affiliates" in the
consolidated statements of income. The three and nine months ended September 30, 2025 also include $51 million of dividends declared but
not paid, included in "Accrued and other current liabilities" in the consolidated balance sheets.
Table of Contents
33
-- 33 of 73 --
NOTE 18 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
A summary of the Company's pension and other postretirement benefit plans can be found in Note 19 to the
Consolidated Financial Statements included in the 2024 10-K. The following table provides the components of the
Company's net periodic benefit cost (credit) for all significant plans:
Net Periodic Benefit Cost (Credit) for All Significant Plans Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Defined Benefit Pension Plans
Service cost $ 12 $ 14 $ 33 $ 42
Interest cost 251 252 746 754
Expected return on plan assets (324) (345) (965) (1,034)
Amortization of prior service credit (4) (3) (10) (10)
Amortization of net loss 42 34 123 105
Settlement cost 1 10 — 10 —
Net periodic benefit credit $ (13) $ (48) $ (63) $ (143)
Other Postretirement Benefit Plans
Service cost $ — $ 1 $ 2 $ 3
Interest cost 11 11 31 33
Amortization of net gain (12) (10) (35) (31)
Net periodic benefit cost (credit) $ (1) $ 2 $ (2) $ 5
1. Related to the settlement of certain plan obligations of a European plan resulting from the 2025 Restructuring Program. See Note 5 for
additional information.
Except for the settlement cost component related to the 2025 Restructuring Program, which is included in
"Restructuring and asset related charges - net" in the consolidated statements of income, the non-service cost
components of net periodic benefit cost (credit) are included in "Sundry income (expense) - net" in the consolidated
statements of income.
NOTE 19 – STOCK-BASED COMPENSATION
A summary of the Company's stock-based compensation plans can be found in Note 20 to the Consolidated
Financial Statements included in the 2024 10-K.
Stock Incentive Plan
The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock
Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first
quarter of each year.
In the first quarter of 2025, Dow Inc. granted the following stock-based compensation awards to employees:
• 1.8 million stock options with a weighted-average exercise price of $38.34 per share and a weighted-
average fair value of $8.27 per share;
• 3.0 million restricted stock units with a weighted-average fair value of $38.34 per share; and
• 2.1 million performance stock units with a weighted-average fair value of $38.46 per share.
There was minimal grant activity in the second and third quarters of 2025.
Employee Stock Purchase Plan
The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Board on February 11,
2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2025 annual
offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued
at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using
the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent
Table of Contents
34
-- 34 of 73 --
of the fair market value (closing price) of the common stock at March 31, 2025 (beginning) or October 3, 2025
(ending) of the offering period, whichever is lower.
In the first quarter of 2025, employees subscribed to the right to purchase shares under the 2021 ESPP. In
October 2025, 4.2 million shares were delivered to employees under the plan.
NOTE 20 – FINANCIAL INSTRUMENTS
A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging
activities can be found in Note 21 to the Consolidated Financial Statements included in the 2024 10-K.
Refer to Note 21 for a summary of the fair value of financial instruments at September 30, 2025 and December 31,
2024.
Debt Securities
The Company's investments in debt securities are primarily classified as available-for-sale. The following table
provides investing results from available-for-sale securities for the nine months ended September 30, 2025 and
2024:
Investing Results Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024
Proceeds from sales of available-for-sale securities $ 320 $ 1,730
Gross realized gains $ 6 $ 34
Gross realized losses $ (9) $ (15)
The following table summarizes contractual maturities of the Company's investments in debt securities:
Contractual Maturities of Debt Securities at Sep 30, 2025
Cost Fair
Value In millions
Within one year $ 113 $ 108
One to five years 1,113 1,039
Six to ten years 446 448
After ten years 549 468
Total $ 2,221 $ 2,063
Equity Securities
There were no material adjustments to the carrying value of the not readily determinable investments for impairment
or observable price changes for the three and nine months ended September 30, 2025. There was $2 million of net
unrealized losses recognized in earnings on equity securities for the three months ended September 30, 2025
($1 million of net unrealized losses for the three months ended September 30, 2024). There was $4 million of net
unrealized losses recognized in earnings on equity securities for the nine months ended September 30, 2025
($1 million of net unrealized losses for the nine months ended September 30, 2024).
Investments in Equity Securities Sep 30,
2025 Dec 31,
2024 In millions
Readily determinable fair value $ 10 $ 14
Not readily determinable fair value $ 170 $ 153
Table of Contents
35
-- 35 of 73 --
Derivative Instruments
The notional amounts of the Company's derivative instruments at September 30, 2025 and December 31, 2024
were as follows:
Notional Amounts 1
Sep 30,
2025 Dec 31,
2024 In millions
Derivatives designated as hedging instruments:
Interest rate contracts $ 500 $ 1,870
Foreign currency contracts $ 6,910 $ 3,144
Derivatives not designated as hedging instruments:
Interest rate contracts $ 353 $ 14
Foreign currency contracts $ 22,776 $ 9,244
1. Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at
the maximum notional position at expiration.
The notional amounts of the Company's commodity derivatives at September 30, 2025 and December 31, 2024
were as follows:
Commodity Notionals 1 Sep 30,
2025 Dec 31,
2024 Notional Volume Unit
Derivatives designated as hedging instruments:
Hydrocarbon derivatives 2.6 3.2 million barrels of oil equivalent
Derivatives not designated as hedging instruments:
Hydrocarbon derivatives 1.0 1.1 million barrels of oil equivalent
1. Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.
Maximum Maturity Dates of Derivatives Designated as Hedging Instruments Year
Interest rate contracts 2027
Foreign currency contracts 2026
Commodity contracts 2028
Table of Contents
36
-- 36 of 73 --
The following table provides the fair value and balance sheet classification of derivative instruments at
September 30, 2025 and December 31, 2024:
Fair Value of Derivative Instruments Sep 30, 2025 Dec 31, 2024
In millions Gross
Counterparty
and Cash
Collateral
Netting 1 Net 2 Gross
Counterparty
and Cash
Collateral
Netting 1 Net 2
Asset derivatives
Derivatives designated as hedging
instruments:
Interest rate contracts 3 $ 1 $ — $ 1 $ 20 $ (20) $ —
Interest rate contracts 4 16 (11) 5 — — —
Foreign currency contracts 3 82 (58) 24 33 (15) 18
Foreign currency contracts 4 7 (6) 1 — — —
Commodity contracts 3 124 (105) 19 25 (14) 11
Commodity contracts 4 74 (65) 9 46 (36) 10
Total $ 304 $ (245) $ 59 $ 124 $ (85) $ 39
Derivatives not designated as hedging
instruments:
Interest rate contracts 3 $ 2 $ (2) $ — $ — $ — $ —
Foreign currency contracts 3 68 (38) 30 74 (16) 58
Commodity contracts 3 20 (9) 11 16 (1) 15
Commodity contracts 4 3 (2) 1 4 (3) 1
Total $ 93 $ (51) $ 42 $ 94 $ (20) $ 74
Total asset derivatives $ 397 $ (296) $ 101 $ 218 $ (105) $ 113
Liability derivatives
Derivatives designated as hedging
instruments:
Interest rate contracts 5 $ — $ — $ — $ 46 $ (20) $ 26
Interest rate contracts 6 11 (11) — — — —
Foreign currency contracts 5 131 (58) 73 75 (15) 60
Foreign currency contracts 6 13 (6) 7 40 — 40
Commodity contracts 5 116 (106) 10 16 (14) 2
Commodity contracts 6 72 (65) 7 37 (36) 1
Total $ 343 $ (246) $ 97 $ 214 $ (85) $ 129
Derivatives not designated as hedging
instruments:
Interest rate contracts 5 $ 2 $ (2) $ — $ 1 $ — $ 1
Foreign currency contracts 5 86 (38) 48 27 (16) 11
Commodity contracts 5 14 (10) 4 8 (1) 7
Commodity contracts 6 3 (2) 1 4 (3) 1
Total $ 105 $ (52) $ 53 $ 40 $ (20) $ 20
Total liability derivatives $ 448 $ (298) $ 150 $ 254 $ (105) $ 149
1. Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in
master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with
the same counterparty.
2. Represents the net amounts included in the consolidated balance sheets.
3. Included in "Other current assets" in the consolidated balance sheets.
4. Included in "Deferred charges and other assets" in the consolidated balance sheets.
5. Included in "Accrued and other current liabilities" in the consolidated balance sheets.
6. Included in "Other noncurrent obligations" in the consolidated balance sheets.
Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional
or exchange contracts executed with the same counterparty under a master netting arrangement are netted.
Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash
collateral of $11 million at September 30, 2025 ($16 million at December 31, 2024). No cash collateral was posted
by counterparties with the Company at September 30, 2025 and December 31, 2024.
Table of Contents
37
-- 37 of 73 --
The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income
and comprehensive income for the three and nine months ended September 30, 2025 and 2024:
Effect of Derivative Instruments Gain (loss) recognized in OCI 1 Gain (loss) recognized in income 2
Three Months Ended Nine Months Ended Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Derivatives designated as hedging
instruments:
Fair value hedges:
Interest rate contracts 3, 4 $ — $ — $ — $ — $ (7) $ 7 $ 26 $ (16)
Excluded components 3, 5 7 51 6 9 — — — —
Cash flow hedges:
Interest rate contracts 3 2 — 2 1 (1) (2) (2) (11)
Foreign currency contracts 6 (22) 16 8 (5) (5) 1 — 6
Foreign currency contracts 7 17 — 2 — — — — —
Commodity contracts 6 (4) — (15) 22 (12) (2) (13) (3)
Excluded components 5, 6 — (2) — (8) (2) (1) (5) (5)
Excluded components 5, 7 — — 7 — 3 — 6 —
Net foreign investment hedges:
Foreign currency contracts — (45) (82) (37) — — — —
Excluded components 5, 7 10 6 41 16 11 5 30 12
Total derivatives designated as
hedging instruments $ 10 $ 26 $ (31) $ (2) $ (13) $ 8 $ 42 $ (17)
Derivatives not designated as
hedging instruments:
Interest rate contracts 3 $ — $ — $ — $ — $ 2 $ — $ 4 $ 1
Foreign currency contracts 7 — — — — 4 (95) (208) (35)
Commodity contracts 6 — — — — (1) (2) (18) —
Commodity contracts 7 — — — — (1) — (1) —
Total return swap 6 — — — — 26 23 50 49
Total derivatives not designated as
hedging instruments $ — $ — $ — $ — $ 30 $ (74) $ (173) $ 15
Total derivatives $ 10 $ 26 $ (31) $ (2) $ 17 $ (66) $ (131) $ (2)
1. OCI is defined as other comprehensive income (loss).
2. Pretax amounts.
3. Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.
4. Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.
5. The excluded components are related to the time value of the derivatives designated as hedges.
6. Included in "Cost of sales" in the consolidated statements of income.
7. Included in "Sundry income (expense) - net" in the consolidated statements of income.
The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the
next 12 months:
Expected Reclassifications from AOCL within the next 12 months Sep 30,
2025 In millions
Cash flow hedges:
Interest rate contracts $ (3)
Commodity contracts $ 6
Foreign currency contracts $ (14)
Net foreign investment hedges:
Excluded components $ 15
Table of Contents
38
-- 38 of 73 --
NOTE 21 – FAIR VALUE MEASUREMENTS
A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 22 to the
Consolidated Financial Statements included in the 2024 10-K.
Fair Value Measurements on a Recurring Basis
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring
basis:
Fair Value Measurements on a
Recurring Basis Sep 30, 2025 Dec 31, 2024
In millions
Fair
Value
Level Cost Gain Loss Fair
Value Cost Gain Loss Fair
Value
Assets at fair value:
Cash equivalents:
Held-to-maturity securities 1 Level 2 $ 854 $ — $ — $ 854 $ 96 $ — $ — $ 96
Money market funds Level 2 960 — — 960 1,164 — — 1,164
Marketable securities 2 Level 2 558 — (61) 497 453 — (70) 383
Other investments:
Debt securities: 3
Government debt 4 Level 2 1,120 8 (82) 1,046 1,103 13 (123) 993
Corporate bonds Level 1 15 — — 15 18 — (1) 17
Corporate bonds Level 2 886 14 (59) 841 954 6 (88) 872
Corporate bonds Level 3 200 — (39) 161 200 — (49) 151
Equity securities 3, 5 Level 1 4 6 — 10 4 10 — 14
Derivatives relating to: 6
Interest rates Level 2 — 19 — 19 — 20 — 20
Foreign currency Level 2 — 157 — 157 — 107 — 107
Commodities Level 1 — 5 — 5 — 4 — 4
Commodities Level 2 — 216 — 216 — 87 — 87
Total assets at fair value $ 4,781 $ 3,908
Liabilities at fair value:
Long-term debt including
debt due within one year 7 Level 2 $ (18,122) $ 1,544 $ (409) $ (16,987) $ (16,208) $ 1,487 $ (484) $ (15,205)
Guarantee liability 8 Level 3 (138) (155)
Derivatives relating to: 6
Interest rates Level 2 — — (13) (13) — — (47) (47)
Foreign currency Level 2 — — (230) (230) — — (142) (142)
Commodities Level 1 — — (3) (3) — — (1) (1)
Commodities Level 2 — — (202) (202) — — (64) (64)
Total liabilities at fair value $ (17,573) $ (15,614)
1. The Company's held-to-maturity securities primarily relate to treasury bills and time deposits. At September 30, 2025, $813 million is included
in "Cash and cash equivalents" ($96 million at December 31, 2024) and $41 million is included in "Other current assets" (zero at December 31,
2024) in the consolidated balance sheets.
2. The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.
3. The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments”
in the consolidated balance sheets.
4. U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.
5. Equity securities with a readily determinable fair value.
6. See Note 20 for classification of derivatives in the consolidated balance sheets.
7. Cost includes fair value hedge adjustment gains of $35 million at September 30, 2025 and $9 million at December 31, 2024 on $5,538 million
of debt at September 30, 2025 and $5,129 million at December 31, 2024.
8. Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance
sheets.
Cost approximates fair value for all other financial instruments.
Table of Contents
39
-- 39 of 73 --
For equity securities calculated at net asset value per share (or its equivalent), the Company had $109 million
in private market securities and $13 million in real estate at September 30, 2025 ($90 million in private market
securities and $15 million in real estate at December 31, 2024). There are no redemption restrictions and the
unfunded commitments on these investments were $72 million at September 30, 2025 and $81 million at
December 31, 2024.
For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including
assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an
investment in a corporate bond, accounted for as a debt security.
For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including
assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to
the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The
estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt
was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without"
values were calculated using a discounted cash flow method based on contractual cash flows as well as projected
prepayments made on the debt by Sadara.
Fair Value Measurements on a Nonrecurring Basis
2025 Restructuring Program
In the second quarter of 2025, the Company recorded a charge for asset write-downs and write-offs, including the
write-down of certain manufacturing facilities, corporate assets, leased, non-manufacturing facilities and other
miscellaneous assets. The manufacturing facilities, corporate assets and certain leased, non-manufacturing
facilities and other miscellaneous assets associated with this plan were written down to zero. In addition,
impairments of certain leased, non-manufacturing facilities and other miscellaneous assets, which were classified
as Level 3 measurements, resulted in a write-down of right-of-use assets to a fair value of $110 million using
unobservable inputs. The Company recorded impairment charges of $334 million for asset write-downs and write-
offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and
related to Packaging & Specialty Plastics ($81 million), Industrial Intermediates & Infrastructure ($63 million),
Performance Materials & Coatings ($147 million) and Corporate ($43 million). In the third quarter of 2025, the
Company recorded additional impairment charges of $8 million for asset write-downs and write-offs, included in
"Restructuring and asset related charges - net" in the consolidated statements of income and related to
Packaging & Specialty Plastics ($3 million), Industrial Intermediates & Infrastructure ($1 million), Performance
Materials & Coatings ($3 million) and Corporate ($1 million).
2023 Restructuring Program
In the first quarter of 2025, the Company recorded impairment charges of $5 million for asset write-downs and write-
offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and
related to Industrial Intermediates & Infrastructure.
NOTE 22 – VARIABLE INTEREST ENTITIES
A summary of the Company's variable interest entities ("VIEs") not discussed below can be found in Note 23 to the
Consolidated Financial Statements included in the 2024 10-K.
Assets and Liabilities of Consolidated VIEs
The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for
which the Company is the primary beneficiary. The other equity holders’ interests are included in “Net income
attributable to noncontrolling interests” in the consolidated statements of income and "Noncontrolling interests" in
the consolidated balance sheets.
Infrastructure Entity
The Company has variable interests in Diamond Infrastructure Solutions, an entity that owns and operates
infrastructure assets at certain Dow locations on the U.S Gulf Coast as discussed in Note 17. The Company's
variable interests relate to its membership interest and the service contracts between Diamond Infrastructure
Solutions and Dow, under which a majority of the infrastructure services are provided to Dow using pass-through
and cost-plus pricing. Diamond Infrastructure Solutions became a variable interest entity effective with the
noncontrolling interest transaction on May 1, 2025. Dow is deemed the primary beneficiary as a result of decision
rights held as the majority member.
Table of Contents
40
-- 40 of 73 --
The following table summarizes the carrying amounts of Diamond Infrastructure Solutions' assets and liabilities
included in the Company’s consolidated balance sheets at September 30, 2025. Amounts presented are adjusted
for intercompany eliminations.
Assets and Liabilities of Diamond Infrastructure Solutions Sep 30,
2025 In millions
Other current assets $ 161
Net property 2,244
Other noncurrent assets 216
Total assets 1 $ 2,621
Current liabilities $ 397
Long-term debt 172
Other noncurrent obligations 340
Total liabilities 2 $ 909
1. All assets were restricted at September 30, 2025.
2. All liabilities were nonrecourse at September 30, 2025.
Other Consolidated VIEs
In addition, the Company holds a variable interest and is the primary beneficiary of other joint ventures and entities.
The following table summarizes the carrying amounts of other entities' assets and liabilities included in the
Company’s consolidated balance sheets at September 30, 2025 and December 31, 2024:
Assets and Liabilities of Other Consolidated VIEs Sep 30,
2025 Dec 31,
2024 In millions
Cash and cash equivalents $ 23 $ 22
Other current assets 210 250
Net property 113 122
Other noncurrent assets 16 15
Total assets 1 $ 362 $ 409
Current liabilities $ 16 $ 24
Other noncurrent obligations 13 13
Total liabilities 2 $ 29 $ 37
1. Restricted assets totaled $187 million and $192 million at September 30, 2025 and December 31, 2024, respectively.
2. All liabilities were nonrecourse at September 30, 2025 and December 31, 2024.
Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse
obligations relating to consolidated VIEs at September 30, 2025 and December 31, 2024 are adjusted for
intercompany eliminations.
NOTE 23 – SEGMENTS AND GEOGRAPHIC REGIONS
Sales to external customers, which are attributed to geographic regions based on customer location, were as
follows:
Sales to External Customers by Geographic Region Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
United States $ 3,651 $ 3,883 $ 11,322 $ 11,621
EMEAI 3,090 3,568 9,636 10,624
Rest of World 3,232 3,428 9,550 10,314
Total $ 9,973 $ 10,879 $ 30,508 $ 32,559
Table of Contents
41
-- 41 of 73 --
Long-lived assets, which are attributed to geographic regions based on asset location, were as follows:
Long-Lived Assets by Geographic Region Sep 30,
2025 Dec 31,
2024 In millions
United States $ 14,914 $ 15,216
EMEAI 2,776 2,726
Rest of World 4,849 4,062
Total $ 22,539 $ 22,004
Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the
chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and
senior vice president of corporate development, together the "executive committee" and CODM, assesses
performance and allocates resources. The CODM compares quarterly results to both the year-ago and sequential
periods to assess performance and allocate resources to each segment. The Company defines Operating EBIT as
earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact of significant items.
Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to
Dow as a whole are assigned to Corporate.
Segment Operating EBIT 1 Pack. &
Spec.
Plastics
Ind.
Interm. &
Infrast.
Perf.
Materials &
Coatings
Operating
Segment
Total In millions
Three months ended Sep 30, 2025
Net sales $ 4,891 $ 2,834 $ 2,082 $ 9,807
Cost of sales 4,474 2,714 1,851 9,039
SARD 2 222 122 158 502
Equity in earnings (losses) of nonconsolidated affiliates (6) (68) 1 (73)
Other segment income (expense) items 3 10 23 6 39
Segment Operating EBIT 4 $ 199 $ (47) $ 80 $ 232
Three months ended Sep 30, 2024
Net sales $ 5,516 $ 2,962 $ 2,214 $ 10,692
Cost of sales 4,675 2,893 1,881 9,449
SARD 2 260 134 169 563
Equity in earnings (losses) of nonconsolidated affiliates 16 (17) 1 —
Other segment income (expense) items 3 21 29 (25) 25
Segment Operating EBIT 4 $ 618 $ (53) $ 140 $ 705
Nine months ended Sep 30, 2025
Net sales $ 15,226 $ 8,475 $ 6,282 $ 29,983
Cost of sales 13,967 8,368 5,510 27,845
SARD 2 683 365 456 1,504
Equity in earnings (losses) of nonconsolidated affiliates 40 (165) 2 (123)
Other segment income (expense) items 3 (4) 63 (37) 22
Segment Operating EBIT 4 $ 612 $ (360) $ 281 $ 533
Nine months ended Sep 30, 2024
Net sales $ 16,461 $ 8,921 $ 6,609 $ 31,991
Cost of sales 13,888 8,472 5,690 28,050
SARD 2 768 397 523 1,688
Equity in earnings (losses) of nonconsolidated affiliates 96 (63) 9 42
Other segment income (expense) items 3 25 52 (78) (1)
Segment Operating EBIT 4 $ 1,926 $ 41 $ 327 $ 2,294
1. Significant expense categories are presented on an operating basis, net of the impact of significant items.
2. SARD includes selling, general and administrative and research and development expenses.
3. Other segment items includes amortization of intangibles and sundry income (expense) - net.
4. Segment Operating EBIT for TDCC for the three and nine months ended September 30, 2025 and 2024 is substantially the same as that of
Dow Inc. and therefore is not disclosed separately in the table above. A reconciliation of "Segment Operating EBIT" to "Income (loss) before
income taxes" is provided in the following table.
Table of Contents
42
-- 42 of 73 --
Reconciliation of "Segment Operating EBIT" to "Income (Loss)
Before Income Taxes" Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Segment Operating EBIT $ 232 $ 705 $ 533 $ 2,294
+ Corporate Operating EBIT (52) (64) (144) (160)
+ Interest income 47 36 114 143
- Interest expense and amortization of debt discount 221 199 646 595
+ Significant items 64 (154) (820) (301)
Income (loss) before income taxes $ 70 $ 324 $ (963) $ 1,381
Other Segment Information Pack. &
Spec.
Plastics
Ind.
Interm. &
Infrast.
Perf.
Materials &
Coatings
Operating
Segment
Total Corp. 1 Total In millions
Three months ended Sep 30, 2025
Net sales $ 4,891 $ 2,834 $ 2,082 $ 9,807 $ 166 $ 9,973
Depreciation and amortization $ 349 $ 158 $ 174 $ 681 $ 7 $ 688
Capital expenditures $ 433 $ 72 $ 59 $ 564 $ — $ 564
Operating EBIT $ 199 $ (47) $ 80 $ 232 $ (52) $ 180
Three months ended Sep 30, 2024
Net sales $ 5,516 $ 2,962 $ 2,214 $ 10,692 $ 187 $ 10,879
Depreciation and amortization $ 384 $ 155 $ 194 $ 733 $ 8 $ 741
Capital expenditures $ 490 $ 165 $ 81 $ 736 $ — $ 736
Operating EBIT $ 618 $ (53) $ 140 $ 705 $ (64) $ 641
Nine months ended Sep 30, 2025
Net sales $ 15,226 $ 8,475 $ 6,282 $ 29,983 $ 525 $ 30,508
Depreciation and amortization $ 1,078 $ 457 $ 566 $ 2,101 $ 25 $ 2,126
Capital expenditures $ 1,458 $ 303 $ 150 $ 1,911 $ — $ 1,911
Operating EBIT $ 612 $ (360) $ 281 $ 533 $ (144) $ 389
Nine months ended Sep 30, 2024
Net sales $ 16,461 $ 8,921 $ 6,609 $ 31,991 $ 568 $ 32,559
Depreciation and amortization $ 1,098 $ 443 $ 578 $ 2,119 $ 24 $ 2,143
Capital expenditures $ 1,434 $ 497 $ 242 $ 2,173 $ — $ 2,173
Operating EBIT $ 1,926 $ 41 $ 327 $ 2,294 $ (160) $ 2,134
1. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. Net sales for Corporate are
primarily related to insurance operations. Corporate expenses are primarily related to insurance operations, salaries and wages and non-
business aligned environmental and legal costs.
Segment Asset Information Pack. &
Spec.
Plastics
Ind.
Interm. &
Infrast.
Perf.
Materials &
Coatings
Operating
Segment
Total Corp. Total In millions
Sep 30, 2025
Total assets $ 30,981 $ 12,739 $ 11,894 $ 55,614 $ 5,376 $ 60,990
Investments in nonconsolidated affiliates 1 $ 675 $ 401 $ 143 $ 1,219 $ 36 $ 1,255
Dec 31, 2024
Total assets $ 29,034 $ 11,928 $ 11,170 $ 52,132 $ 5,180 $ 57,312
Investments in nonconsolidated affiliates 1 $ 711 $ 367 $ 146 $ 1,224 $ 42 $ 1,266
1. See Note 10 for additional information regarding the Company's investments in nonconsolidated affiliates.
Table of Contents
43
-- 43 of 73 --
The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:
Significant Items by Segment
In millions
Pack. &
Spec.
Plastics
Ind.
Interm. &
Infrast. Perf. Mat.
& Coatings
Operating
Segment
Total Corp. Total
Three months ended Sep 30, 2025
2025 Restructuring Program severance and
related benefit costs and asset related charges 1 $ (3) $ (6) $ (3) $ (12) $ (11) $ (23)
Implementation costs 2 — — — — (5) (5)
Net gain on divestitures and asset sale 3 — — — — 110 110
Loss on early extinguishment of debt 4 — — — — (18) (18)
Total significant items by segment $ (3) $ (6) $ (3) $ (12) $ 76 $ 64
Nine months ended Sep 30, 2025
Restructuring, implementation and efficiency
costs, and asset related charges - net 5 $ — $ (1) $ — $ (1) $ (50) $ (51)
2025 Restructuring Program severance and
related benefit costs and asset related charges 1 (161) (95) (150) (406) (415) (821)
Implementation costs 2 — — — — (10) (10)
Net gain on divestitures and asset sale 3 — 103 — 103 110 213
Litigation related charges, awards and
adjustments 6 — — — — 42 42
Loss on early extinguishment of debt 4 — — — — (78) (78)
Indemnification and other transaction related
costs 7 — — — — (115) (115)
Total significant items by segment $ (161) $ 7 $ (150) $ (304) $ (516) $ (820)
1. Severance and related benefit costs and impairment charges related to the write-down of certain manufacturing facilities, corporate assets, leased non-
manufacturing facilities and other miscellaneous assets associated with the Company's 2025 Restructuring Program. See Note 5 for additional
information.
2. Implementation costs associated with the Company's 2025 Restructuring Program and the sale of membership interests of Diamond Infrastructure
Solutions.
3. The three and nine months ended September 30, 2025 relate to a gain on the sale of the Company's ownership interest in a nonconsolidated affiliate.
The nine months ended September 30, 2025 also includes a gain on the sale of the soil fumigation product line. See Note 4 for additional information.
4. The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 13 for additional information.
5. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The nine months
ended September 30, 2024 also includes impairment charges related to the write-down of certain manufacturing assets, partially offset by an asset
related credit adjustment. See Note 5 for additional information.
6. Includes a gain associated with the reassessment of liabilities for certain accrued Groundwater Matters, partially offset by the settlement of a separate
claim related to water storage district Groundwater Matters. See Note 14 for additional information.
7. Charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters,
provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation. The nine
months ended September 30, 2025 also includes a charge related to an arbitration settlement agreement for historical product claims from a divested
business. See Note 14 for additional information.
Significant Items by Segment Pack. &
Spec.
Plastics
Ind.
Interm. &
Infrast.
Perf.
Materials
& Coatings
Operating
Segment
Total Corp. Total In millions
Three months ended Sep 30, 2024
Restructuring, implementation and efficiency
costs, and asset related charges - net 1 $ — $ — $ (7) $ (7) $ (72) $ (79)
Indemnification and other transactions related
costs 2 — — — — (75) (75)
Total significant items by segment $ — $ — $ (7) $ (7) $ (147) $ (154)
Nine months ended Sep 30, 2024
Restructuring, implementation and efficiency
costs, and asset related charges - net 1 $ (37) $ (8) $ (7) $ (52) $ (174) $ (226)
Indemnification and other transactions related
costs 2 — — — — (75) (75)
Total significant items by segment $ (37) $ (8) $ (7) $ (52) $ (249) $ (301)
1. Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The nine months
ended September 30, 2024 also includes impairment charges related to the write-down of certain manufacturing assets.
2. Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. See Note 14 for additional
information.
Table of Contents
44
-- 44 of 73 --
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS.
This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company
and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the "Company") due to the parent/
subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to
both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this
report on its own behalf and neither company makes any representation to the information relating to the other
company.
Pursuant to General Instruction H(1)(a) and (b) for Form 10-Q "Omission of Information by Certain Wholly-Owned
Subsidiaries," TDCC is filing this Form 10-Q with a reduced disclosure format.
Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation, a wholly
owned subsidiary of the Company. Additionally, the term "Diamond Infrastructure Solutions" means Dow InfraCo,
LLC, an entity that owns and operates infrastructure assets at certain Dow locations on the U.S. Gulf Coast and
became a consolidated variable interest entity upon the sale of a portion of the entity's membership interests on
May 1, 2025. The term "EMEAI" refers to the geographic region of Europe, Middle East, Africa and India.
Dow's website and its content are not deemed incorporated by reference into this report.
STATEMENT ON MACROECONOMIC CONDITIONS AND FOURTH QUARTER OUTLOOK
Overview of Macroeconomic Conditions and the Company’s Response
The Company has continued to face challenging market conditions, including the significant impact of slower global
GDP growth, through the third quarter of 2025. Industry overcapacity due to newer entrants exporting at anti-
competitive economics has, and is expected to continue to, negatively impact the Company’s results of operations
and cash flows. In addition, the current uncertain geopolitical environment, including the impact of trade policies,
has resulted in increased volatility in global markets, also negatively impacting the Company’s results of operations
and cash flows. The macroeconomic conditions experienced in the first nine months of 2025 are expected to persist
in the near term for the Company and the industry alike.
Despite these challenges, the Company has maintained a strong financial position and solid liquidity and has taken
actions to mitigate impacts on its supply chain and results of operations. At the time of this filing, the ultimate impact
of tariff policies and other evolving global trade measures, coupled with existing macroeconomic challenges, is
uncertain. The Company is actively monitoring global trade developments to identify actions necessary to maintain
competitiveness while it adapts to these new economic challenges and continuing to work with regulatory bodies to
address anti-competitive behavior. More information on these risks and potential impact to the Company can be
found in Part II, Item 1A. Risk Factors.
In the first quarter of 2025, Dow announced targeted cost actions to reduce structural costs by $1 billion over the
next two years, while its businesses work to balance supply with profitable demand. The cost actions target areas
such as third-party spending and include a workforce reduction of approximately 1,500 roles. The Company also
announced reductions to its capital expenditures for 2025.
The Company announced further actions to address ongoing macroeconomic volatility and persistently slower
global GDP growth in the second quarter of 2025, including the decision to delay construction of its Path2Zero
project in Fort Saskatchewan, Alberta, Canada, until market conditions improve, reducing the Company’s expected
2025 enterprise-wide capital expenditures to $2.5 billion, a reduction from the Company's original plan of
$3.5 billion. Dow remains committed to its Path2Zero project and the growth upside it will enable in targeted
applications like pressure pipe, wire and cable, and food packaging. The Path2Zero project is expected to be the
world’s first net-zero Scope 1 and 2 carbon dioxide equivalent emissions integrated ethylene and derivatives
complex.
On July 7, 2025, the Company announced additional restructuring actions, approved by its Board of Directors
("Board") on June 30, 2025, to rationalize its global asset footprint, including actions related to the three assets
identified as part of the Company’s expanded strategic review of its European assets and certain corporate and
other assets, and to enhance the Company’s competitiveness over the economic cycle. The program includes asset
Table of Contents
45
-- 45 of 73 --
write-down and write-off charges, severance and related benefit costs, contract termination fees and other exit and
disposal costs. These actions will be completed by the Company primarily over the next four years, including the
asset shut downs and completion of the related decommissioning and demolition activities. Significant actions
approved to date include the following:
• Packaging & Specialty Plastics will shut down an ethylene facility in Böhlen, Germany by the end of 2027.
• Industrial Intermediates & Infrastructure will shut down chlor-alkali and vinyl assets in Schkopau, Germany
by the end of 2027.
• Performance Materials & Coatings will shut down a basics siloxanes plant in Barry, United Kingdom by mid-
year 2026.
• The Company will write-off certain Corporate-aligned owned and leased non-manufacturing facilities and
other assets.
More information on the restructuring actions and related charges can be found in Note 5 to the Consolidated
Financial Statements.
On July 24, 2025, the Company’s Board declared a quarterly dividend of $0.35 per share, reducing the dividend by
50 percent compared with the dividend declared in second quarter 2025, in response to the prolonged industry
downturn. The adjustment to the size of the dividend reflects the Company’s balanced capital allocation approach
and enhances financial flexibility amidst a persistently challenging macroeconomic environment. The Company's
fourth quarter dividend of $0.35 per share was declared by the Board on October 9, 2025.
Outlook
The Company is staying close with its customers, maintaining the financial flexibility it has built, and strengthening
its competitiveness to drive higher earnings. While the near-term market backdrop remains largely unchanged
across the end markets Dow serves, the Company continues to take actions to build on its strong foundation and
enable greater long-term shareholder returns when macroeconomic conditions improve. Dow is focused on resilient
areas of its portfolio where it can capture share and premiums. And, the Company is delivering increased cost
savings, rationalizing higher-cost areas of its asset footprint, primarily in Europe, and applying a disciplined
approach to its balance sheet and cash flow. As it has demonstrated, Dow is committed to identifying and
implementing additional targeted initiatives designed to enhance its earnings and further optimize its cost structure.
OVERVIEW
The following is a summary of the results for the three months ended September 30, 2025:
• The Company reported net sales in the third quarter of 2025 of $10.0 billion, down 8 percent from $10.9 billion
in the third quarter of 2024, and down in all operating segments; Packaging & Specialty Plastics (down
11 percent), Industrial Intermediates & Infrastructure (down 4 percent) and Performance Materials & Coatings
(down 6 percent). Net sales decreased in all geographic regions; the U.S. & Canada (down 6 percent), EMEAI
(down 13 percent), Latin America (down 11 percent) and Asia Pacific (down 3 percent).
• Local price decreased 8 percent compared with the third quarter of 2024, and was down in all operating
segments; Packaging & Specialty Plastics (down 10 percent), Industrial Intermediates & Infrastructure (down
8 percent) and Performance Materials & Coatings (down 5 percent). Local price was down in all geographic
regions; the U.S. & Canada and Asia Pacific (both down 9 percent) and EMEAI and Latin America (both down
8 percent).
• Volume decreased 1 percent compared with the third quarter of 2024 and was mixed by operating segment;
Packaging & Specialty Plastics (down 1 percent), Industrial Intermediates & Infrastructure (up 2 percent) and
Performance Materials & Coatings (down 2 percent). Volume increased in Asia Pacific (up 6 percent) and the
U.S. & Canada (up 3 percent), and was more than offset by a decrease in EMEAI (down 8 percent) and Latin
America (down 3 percent).
• Currency had a favorable impact of 1 percent on net sales compared with the third quarter of 2024, driven by
EMEAI (up 4 percent).
Table of Contents
46
-- 46 of 73 --
• Equity in losses of nonconsolidated affiliates was $72 million in the third quarter of 2025, compared with equity
in earnings of nonconsolidated affiliates of $2 million in the third quarter of 2024, primarily due to lower results at
the Company's principal joint ventures, including the impact of an unplanned event at Sadara.
• Net income attributable to noncontrolling interests was $62 million in the third quarter of 2025, compared with
$26 million in the third quarter of 2024. The increase reflects the ownership interest in Diamond Infrastructure
Solutions held by InfraPark Holdings, LLC ("InfraPark"), a subsidiary of a fund managed by Macquarie Asset
Management. InfraPark purchased 40 percent of the membership interests in Diamond Infrastructure Solutions
in the second quarter of 2025 and an additional 9 percent in the third quarter of 2025.
• Net income available for Dow Inc. and TDCC common stockholder(s) was $62 million in the third quarter of
2025, compared with $214 million and $224 million, respectively, in the third quarter of 2024. Earnings per share
for Dow Inc. was $0.08 per share in the third quarter of 2025, compared with $0.30 per share in the third quarter
of 2024.
• Cash provided by operating activities - continuing operations was $1,130 million in the third quarter of 2025,
compared with $800 million in the third quarter of 2024. Cash provided by operating activities - continuing
operations was up $1,600 million compared with the second quarter of 2025, primarily driven by working capital
improvements and advance payments received from customers for low carbon solutions and other long-term
supply agreements.
• On July 7, 2025, Moody's Ratings announced a long-term credit rating change for TDCC from Baa1 to Baa2
and affirmed TDCC's P-2 rating and its outlook of negative.
• On July 24, 2025, Dow Inc. announced that its Board declared a dividend of $0.35 per share, payable on
September 12, 2025, to shareholders of record as of August 29, 2025. This marks the 456th consecutive
dividend paid by the Company or its affiliates since 1912.
• On July 31, 2025, Fitch Ratings announced a long-term credit rating change for TDCC from BBB+ to BBB and a
short-term credit rating change from F1 to F2, with its outlook remaining stable.
• On August 8, 2025, the Company sold its ownership interest in DowAksa Advanced Composites Holdings BV
("DowAksa"), a nonconsolidated affiliate, to its joint venture partner, Aksa Akrilik Kimya Sanayii A.Ş., for cash
proceeds of $121 million, net of costs to sell and other transaction expenses and subject to customary post-
closing adjustments.
• On August 29, 2025, the Company received approximately $540 million of additional proceeds following
InfraPark's purchase of an additional 9 percent of the membership interests of Diamond Infrastructure Solutions,
increasing its minority equity stake from 40 percent to 49 percent, and bringing the total proceeds from the
transaction to approximately $3 billion.
• On September 3, 2025, TDCC issued $1.4 billion of senior unsecured notes.
In addition, the following events occurred subsequent to the third quarter of 2025:
• On October 9, 2025, Dow Inc. announced that its Board declared a dividend of $0.35 per share, payable on
December 12, 2025, to shareholders of record as of November 28, 2025. This marks the 457th consecutive
dividend paid by the Company or its affiliates since 1912.
Table of Contents
47
-- 47 of 73 --
RESULTS OF OPERATIONS
Net Sales
The following tables summarize net sales and sales variances by operating segment and geographic region from
the prior year:
Summary of Sales Results Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net sales $ 9,973 $ 10,879 $ 30,508 $ 32,559
Sales Variances
by Operating
Segment and
Geographic
Region
Three Months Ended Sep 30, 2025 Nine Months Ended Sep 30, 2025
Local
Price &
Product
Mix Currency Volume Portfolio
& Other 1 Total
Local
Price &
Product
Mix Currency Volume Portfolio
& Other 1 Total
Percentage change
from prior year
Packaging &
Specialty Plastics (10) % 1 % (1) % (1) % (11) % (8) % — % 1 % (1) % (8) %
Industrial
Intermediates &
Infrastructure (8) 2 2 — (4) (5) — — — (5)
Performance
Materials &
Coatings (5) 1 (2) — (6) (3) — (2) — (5)
Total (8) % 1 % (1) % — % (8) % (6) % — % — % — % (6) %
Total, excluding the
Hydrocarbons &
Energy business (8) % 1 % — % — % (7) % (6) % — % — % (1) % (7) %
U.S. & Canada (9) % — % 3 % — % (6) % (5) % — % 3 % (1) % (3) %
EMEAI (8) 4 (8) (1) (13) (6) 1 (3) (1) (9)
Asia Pacific (9) — 6 — (3) (8) — 3 — (5)
Latin America (8) — (3) — (11) (8) — (4) — (12)
Total (8) % 1 % (1) % — % (8) % (6) % — % — % — % (6) %
1. Portfolio & Other includes the sales impact of the flexible packaging laminating adhesives business, which was sold to Arkema S.A. in the
fourth quarter of 2024.
Net sales in the third quarter of 2025 were $10.0 billion, down 8 percent from $10.9 billion in the third quarter of
2024, with local price down 8 percent, volume down 1 percent, and a favorable currency impact of 1 percent. Net
sales decreased in all operating segments and all geographic regions. Local price decreased in all geographic
regions and all operating segments, with Packaging & Specialty Plastics down 10 percent, Industrial
Intermediates & Infrastructure down 8 percent, and Performance Materials & Coatings down 5 percent. Volume
decreased 1 percent, driven by EMEAI (down 8 percent) and Latin America (down 3 percent), partially offset by
increases in Asia Pacific (up 6 percent) and the U.S. & Canada (up 3 percent). Volume decreased in Packaging &
Specialty Plastics (down 1 percent), increased in Industrial Intermediates & Infrastructure (up 2 percent) and
decreased in Performance Materials & Coatings (down 2 percent). Currency favorably impacted net sales by
1 percent, driven by EMEAI (up 4 percent). Portfolio & other unfavorably impacted net sales in Packaging &
Specialty Plastics (down 1 percent). Excluding the Hydrocarbons & Energy business, net sales decreased
7 percent.
Net sales for the first nine months of 2025 were $30.5 billion, down 6 percent from $32.6 billion in the same period
last year, with local price down 6 percent, and volume and currency both flat. Net sales decreased in all operating
segments and all geographic regions. Local price decreased in all geographic regions and all operating segments,
with Packaging & Specialty Plastics down 8 percent, Industrial Intermediates & Infrastructure down 5 percent, and
Performance Materials & Coatings down 3 percent. Volume was flat, with gains in Asia Pacific and the U.S. &
Canada (both up 3 percent) offset by declines in Latin America (down 4 percent) and EMEAI (down 3 percent).
Volume increased in Packaging & Specialty Plastics (up 1 percent), was flat in Industrial Intermediates &
Infrastructure, and declined in Performance Materials & Coatings (down 2 percent). Portfolio & other unfavorably
impacted net sales in Packaging & Specialty Plastics (down 1 percent). Excluding the Hydrocarbons & Energy
business, net sales decreased 7 percent.
Table of Contents
48
-- 48 of 73 --
Cost of Sales
Cost of sales ("COS") was $9.2 billion in the third quarter of 2025, compared with $9.8 billion in the third quarter of
2024. COS decreased in the third quarter of 2025 primarily due to lower raw material, feedstock and energy costs,
lower planned maintenance turnaround spending, the impact of the Company's cost reduction initiatives and the
absence of a charge in the third quarter of 2024 related to an arbitration settlement agreement for historical product
claims from a divested business. For the first nine months of 2025, COS was $28.5 billion, compared with
$28.9 billion in the first nine months of 2024. COS for the first nine months of 2025 decreased primarily due to lower
raw material, feedstock and energy costs, lower planned maintenance turnaround spending, adjustments to legacy
groundwater contamination matters and the absence of a charge in the third quarter of 2024 related to an arbitration
settlement agreement for historical product claims from a divested business. COS as a percentage of net sales was
92.7 percent in the third quarter of 2025 (90.2 percent in the third quarter of 2024) and 93.5 percent for the first nine
months of 2025 (88.7 percent for the first nine months of 2024).
Research and Development Expenses
Research and development ("R&D") expenses totaled $191 million in the third quarter of 2025, compared with
$208 million in the third quarter of 2024. R&D expenses for the first nine months of 2025 were $579 million,
compared with $608 million in the first nine months of 2024. R&D expenses for the three and nine months ended
September 30, 2025 decreased primarily due to the Company's cost reduction initiatives.
Selling, General and Administrative Expenses
Selling, general and administrative ("SG&A") expenses totaled $340 million in the third quarter of 2025, compared
with $396 million in the third quarter of 2024. For the first nine months of 2025, SG&A expenses were
$1,053 million, compared with $1,228 million in the first nine months of 2024. SG&A expenses for the three and nine
months ended September 30, 2025 decreased primarily due to the impact of lower third-party purchased services,
the impact of the Company's cost reduction initiatives, as well as decreased bad debt expense. The first nine
months of 2025 also included the impact of a favorable resolution of a dispute with a customer.
Amortization of Intangibles
Amortization of intangibles was $46 million in the third quarter of 2025 compared with $76 million in the third quarter
of 2024. In the first nine months of 2025, amortization of intangibles was $185 million, compared with $234 million in
the first nine months of 2024. Amortization of intangibles decreased primarily due to certain intangible assets
becoming fully amortized in 2025.
Restructuring and Asset Related Charges - Net
2025 Restructuring Program
On January 27, 2025, the Board approved targeted actions to further achieve the Company's cost reduction
initiatives in response to ongoing macroeconomic uncertainty, while reinforcing its long-term competitiveness across
the economic cycle. As a result of these actions, in the first quarter of 2025 the Company recorded pretax charges
of $207 million for severance and related benefits costs, related to Corporate. These actions are expected to be
substantially complete by the end of 2026.
On June 30, 2025, the Board approved restructuring actions to rationalize the Company's global asset footprint,
including certain actions identified as part of the Company's previously announced strategic review of its European
assets and certain corporate and other assets, and to enhance the Company's competitiveness over the economic
cycle. The program includes asset write-down and write-off charges, severance and related benefit costs and other
exit and disposal costs. As a result of these actions, in the second quarter of 2025 the Company recorded pretax
restructuring charges of $591 million, consisting of severance and related benefit costs of $154 million, asset write-
downs and write-offs of $334 million and costs associated with exit and disposal activities of $103 million.
Restructuring charges by segment were as follows: $158 million in Packaging & Specialty Plastics, $89 million in
Industrial Intermediates & Infrastructure, $147 million in Performance Materials & Coatings and $197 million in
Corporate. In the third quarter of 2025, the Company recorded additional pretax restructuring charges of $23 million,
consisting of asset write-downs and write-offs of $8 million and costs associated with exit and disposal activities of
$15 million. The additional restructuring charges by segment were as follows: $3 million in Packaging & Specialty
Plastics, $6 million in Industrial Intermediates & Infrastructure, $3 million in Performance Materials & Coatings and
$11 million in Corporate. See Note 5 to the Consolidated Financial Statements for additional information.
Table of Contents
49
-- 49 of 73 --
2023 Restructuring Program
Actions related to the restructuring program approved by the Board on January 25, 2023 were complete at the end
of the second quarter of 2025. In the first quarter of 2025, the Company recorded an additional pretax restructuring
charge of $5 million for asset write-downs and write-offs and an asset related credit adjustment of $4 million, related
to Industrial Intermediates & Infrastructure. See Note 5 to the Consolidated Financial Statements for additional
information.
Equity in Earnings (Losses) of Nonconsolidated Affiliates
The Company's share of equity in losses of nonconsolidated affiliates was $72 million in the third quarter of 2025,
compared with equity in earnings of nonconsolidated affiliates of $2 million in the third quarter of 2024. The
Company's share of equity in losses of nonconsolidated affiliates was $122 million for the first nine months of 2025,
compared with equity in earnings of nonconsolidated affiliates of $45 million for the first nine months of 2024. The
decrease in both periods was primarily driven by lower results at the Company's Thai, Kuwait and Sadara joint
ventures. Cash dividends from nonconsolidated affiliates were $190 million for the first nine months of 2025,
compared with $266 million for the first nine months of 2024.
Sundry Income (Expense) – Net
Sundry income (expense) - net for the three months ended September 30, 2025 was income of $185 million and
$184 million for Dow Inc. and TDCC, respectively, compared with income of $119 million and $118 million,
respectively, for the three months ended September 30, 2024. The third quarter of 2025 included a gain from the
divestiture of the Company's ownership interest in DowAksa, non-operating pension and postretirement benefit plan
credits and foreign currency exchange gains, partially offset by a loss on early extinguishment of debt. The third
quarter of 2024 included non-operating pension and postretirement benefit plan credits, gains on the sales of assets
and investments and foreign currency exchange losses. See Note 6 to the Consolidated Financial Statements for
additional information.
Sundry income (expense) - net for the nine months ended September 30, 2025 was income of $345 million and
$360 million for Dow Inc. and TDCC, respectively, compared with income of $256 million and $253 million,
respectively, for the nine months ended September 30, 2024. The first nine months of 2025 included a gain from the
divestiture of the Company's soil fumigation product line and its ownership interest in DowAksa, non-operating
pension and postretirement benefit plan credits, and foreign currency exchange gains, partially offset by a loss on
early extinguishment of debt. The first nine months of 2024 included non-operating pension and postretirement
benefit plan credits and gains on the sales of assets and investments, partially offset by foreign currency exchange
losses. See Note 6 to the Consolidated Financial Statements for additional information.
Interest Expense and Amortization of Debt Discount
Interest expense and amortization of debt discount was $221 million in the third quarter of 2025, compared with
$199 million in the third quarter of 2024. Interest expense and amortization of debt discount was $646 million in the
first nine months of 2025, compared with $595 million in the first nine months of 2024. The increase in interest
expense was primarily due to increased issuances of commercial paper during the first nine months of 2025. See
Liquidity and Capital Resources in Management's Discussion and Analysis of Financial Condition and Results of
Operations and Note 13 to the Consolidated Financial Statements for additional information.
Provision (Credit) for Income Taxes
The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of
income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity
method investments are taxed at the joint venture level. In the third quarter of 2025, the Company reported a credit
for income taxes of $54 million, resulting in a negative effective tax rate of 77.1 percent. In the third quarter of 2024,
the Company reported a provision for income taxes of $84 million, resulting in an effective tax rate of 25.9 percent
and 25.1 percent for Dow Inc. and TDCC, respectively. For the first nine months of 2025, the Company reported a
provision for income taxes of $4 million, resulting in a negative effective tax rate of 0.4 percent. For the first nine
months of 2024, the Company reported a provision for income taxes of $145 million, resulting in an effective tax rate
of 10.5 percent and 10.4 percent for Dow Inc. and TDCC, respectively.
The credit for income taxes for the third quarter of 2025 was impacted by the recording of a tax benefit stemming
from the U.S. Tax Court's decision in Varian Medical Systems Inc. v. Commissioner of $100 million and a tax benefit
of $20 million related to the sale of an additional portion of the Company's membership interests in Diamond
Infrastructure Solutions, partially offset by losses attributable to jurisdictions for which no tax benefit can be
recognized. The provision for income taxes for the first nine months of 2025 was also impacted by the initial sale of
Table of Contents
50
-- 50 of 73 --
a portion of the Company's membership interests in Diamond Infrastructure Solutions resulting in a tax benefit of
$89 million, which was offset by valuation allowances in certain foreign jurisdictions of $242 million. See Note 17 to
the Consolidated Financial Statements for additional information related to the Diamond Infrastructure Solutions
transaction. In the first quarter of 2024, the Company recorded a tax credit of $194 million related to a reassessment
of interest and penalties on a tax matter in a foreign jurisdiction, resulting in a reduced effective tax rate for the first
nine months of 2024.
The Company continues to monitor and evaluate legislative developments related to the Global Anti-Base Erosion
Proposal Regime ("GloBE") established by the Organization of Economic Cooperation and Development’s
("OECD") Pillar Two framework. Several countries in which the Company operates have adopted GloBE into their
legislation and several others are expected to enact these rules in the future. To date, such legislation has not
materially impacted the Company's effective tax rate.
On July 4, 2025, U.S. legislation formally titled "An Act to Provide for Reconciliation Pursuant to Title II of H. Con.
Res. 14” (“the Act”) and commonly referred to as the One Big Beautiful Bill Act was signed into law. The Act, among
other things, extended key provisions of the 2017 Tax Cuts and Jobs Act and introduced targeted changes to the
U.S. federal income tax regime. Based on the analysis performed by the Company to date, the Act is not expected
to have a material impact on the effective tax rate.
Net Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests was $62 million in the third quarter of 2025, compared with
$26 million in the third quarter of 2024. Net income attributable to noncontrolling interests was $113 million in the
first nine months of 2025, compared with $67 million for the first nine months of 2024. The increase in net income
attributable to noncontrolling interests was primarily driven by the initial sale of 40 percent of the membership
interests of Diamond Infrastructure Solutions in the second quarter of 2025 and the sale of an additional 9 percent in
the third quarter of 2025. See Notes 17 and 22 to the Consolidated Financial Statements for additional information.
Net Income (Loss) Available for Common Stockholder(s)
Dow Inc.
Net income (loss) available for Dow Inc. common stockholders was income of $62 million, or $0.08 per share, in the
third quarter of 2025, compared with income of $214 million, or $0.30 per share, in the third quarter of 2024. Net
income (loss) available for Dow Inc. common stockholders was a loss of $1,080 million, or $1.53 per share, in the
first nine months of 2025, compared with income of $1,169 million, or $1.65 per share, in the first nine months of
2024. See Note 8 to the Consolidated Financial Statements for details on Dow Inc.'s earnings per share
calculations.
TDCC
Net income (loss) available for the TDCC common stockholder was income of $62 million in the third quarter of
2025, compared with income of $224 million in the third quarter of 2024. Net income (loss) available for the TDCC
common stockholder was a loss of $1,059 million in the first nine months of 2025, compared with income of
$1,186 million in the first nine months of 2024. TDCC's common shares are owned solely by Dow Inc.
SEGMENT RESULTS
For further discussion of the Company's segments, see Part I, Item 1. Business of the combined Dow Inc. and
TDCC Annual Report on Form 10-K for the fiscal year ended December 31, 2024 ("2024 10-K"), filed with the SEC
on February 4, 2025.
Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the
chief executive officer, chief operating officer, chief financial officer, general counsel and corporate secretary, and
senior vice president of corporate development, together the "executive committee" and chief operating decision
maker ("CODM"), assesses performance and allocates resources. The CODM compares quarterly results to both
the year-ago and sequential periods to assess performance and allocate resources to each segment. The Company
defines Operating EBIT as earnings (i.e., "Income (loss) before income taxes") before interest, excluding the impact
of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that
principally apply to Dow as a whole are assigned to Corporate. See Note 23 to the Consolidated Financial
Statements for reconciliations of these measures.
Table of Contents
51
-- 51 of 73 --
PACKAGING & SPECIALTY PLASTICS
Packaging & Specialty Plastics Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net sales $ 4,891 $ 5,516 $ 15,226 $ 16,461
Operating EBIT $ 199 $ 618 $ 612 $ 1,926
Equity earnings (losses) $ (6) $ 16 $ 40 $ 96
Packaging & Specialty Plastics Three Months Ended Nine Months Ended
Percentage change from prior year Sep 30, 2025 Sep 30, 2025
Change in Net Sales from Prior Period due to:
Local price & product mix (10) % (8) %
Currency 1 —
Volume (1) 1
Portfolio & other 1 (1) (1)
Total (11) % (8) %
1. Portfolio & other includes the sales impact of the flexible packaging laminating adhesives business, which was sold to Arkema S.A. in the
fourth quarter of 2024.
Packaging & Specialty Plastics net sales were $4,891 million in the third quarter of 2025, down 11 percent from net
sales of $5,516 million in the third quarter of 2024, with local price down 10 percent, both volume and portfolio &
other down 1 percent and currency up 1 percent. Local price decreased in Packaging and Specialty Plastics in all
geographic regions, driven by lower pricing of polyethylene and functional polymers. Local price decreased in
Hydrocarbons & Energy, driven by olefins and aromatics in EMEAI and the U.S. & Canada. Volume decreased in
Packaging and Specialty Plastics due to nonrecurring licensing sales in the year ago period, partially offset by
higher polyethylene volumes. Volume decreased in Hydrocarbons & Energy, primarily due to lower merchant olefins
sales in EMEAI. Currency had a favorable impact on sales in both businesses and was primarily driven by EMEAI.
Operating EBIT was $199 million in the third quarter of 2025, down $419 million from Operating EBIT of $618 million
in the third quarter of 2024. Operating EBIT decreased primarily due to lower integrated margins and equity
earnings at the EQUATE and Sadara joint ventures, which were partially offset by the impact of the Company's cost
reduction initiatives and lower planned maintenance costs.
Packaging & Specialty Plastics net sales were $15,226 million in the first nine months of 2025, down 8 percent from
net sales of $16,461 million in the first nine months of 2024, with local price down 8 percent, portfolio & other down
1 percent, and volume up 1 percent. Local price decreased in Packaging and Specialty Plastics in all geographic
regions, primarily driven by lower pricing of polyethylene and functional polymers. Local price decreased in
Hydrocarbons & Energy, driven by olefins and aromatics in EMEAI and the U.S. & Canada. Volume increased in
Packaging and Specialty Plastics, with higher volumes in Asia Pacific partially offset by a decline in EMEAI and
Latin America, driven by higher volumes in polyethylene and nonrecurring licensing sales partially offset by lower
functional polymers volumes. Volume increased in Hydrocarbons & Energy, primarily due to higher energy sales in
the U.S. & Canada.
Operating EBIT was $612 million in the first nine months of 2025, down $1,314 million from Operating EBIT of
$1,926 million in the first nine months of 2024. Operating EBIT decreased primarily due to lower integrated margins
and equity earnings at the Company's EQUATE and Thai joint ventures, partially offset by lower planned
maintenance costs.
Table of Contents
52
-- 52 of 73 --
INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE
Industrial Intermediates & Infrastructure Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net sales $ 2,834 $ 2,962 $ 8,475 $ 8,921
Operating EBIT $ (47) $ (53) $ (360) $ 41
Equity losses $ (68) $ (17) $ (165) $ (63)
Industrial Intermediates & Infrastructure Three Months Ended Nine Months Ended
Percentage change from prior year Sep 30, 2025 Sep 30, 2025
Change in Net Sales from Prior Period due to:
Local price & product mix (8) % (5) %
Currency 2 —
Volume 2 —
Total (4) % (5) %
Industrial Intermediates & Infrastructure net sales were $2,834 million in the third quarter of 2025, down 4 percent
from net sales of $2,962 million in the third quarter of 2024, with local price down 8 percent, and both volume and
currency up 2 percent. Local price decreased in both businesses and across all geographic regions, led by declines
in industrial and building and construction applications. Volume increased in Industrial Solutions, driven by higher
volumes from improved supply availability following planned maintenance activity and the startup of a new
alkoxylation unit in Seadrift, Texas, and was led by energy applications. Volume was flat in Polyurethanes &
Construction Chemicals as increased methylene diphenyl diisocyanate volumes following a third-party supplier
outage in the prior year were offset by declines in consumer durables applications. Currency had a favorable impact
on sales in both businesses and was driven by EMEAI.
Operating EBIT was a loss of $47 million in the third quarter of 2025, up $6 million from an Operating EBIT loss of
$53 million in the third quarter of 2024. Operating EBIT increased primarily driven by lower raw material and energy
costs, lower planned maintenance activity, increased volume, and the impact of the Company's cost reduction
initiatives, mostly offset by lower selling prices in both businesses and lower results at the Sadara and EQUATE
joint ventures.
Industrial Intermediates & Infrastructure net sales were $8,475 million in the first nine months of 2025, down
5 percent from net sales of $8,921 million in the first nine months of 2024, with local price down 5 percent. Local
price decreased in both businesses and across all geographic regions, led by declines in industrial, consumer
durables and building and construction applications. Volume increased in Industrial Solutions, with higher volumes
in the U.S. & Canada and EMEAI, primarily in energy and industrial applications. Volume decreased in
Polyurethanes & Construction Chemicals, driven by declines in EMEAI and Latin America, primarily in consumer
durables and industrial applications.
Operating EBIT was a loss of $360 million in the first nine months of 2025, down $401 million from Operating EBIT
of $41 million in the first nine months of 2024. Operating EBIT decreased primarily due to margin compression and
lower results at the EQUATE and Sadara joint ventures, partially offset by the impact of the Company's cost
reduction initiatives.
Table of Contents
53
-- 53 of 73 --
PERFORMANCE MATERIALS & COATINGS
Performance Materials & Coatings Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net sales $ 2,082 $ 2,214 $ 6,282 $ 6,609
Operating EBIT $ 80 $ 140 $ 281 $ 327
Equity earnings $ 1 $ 1 $ 2 $ 9
Performance Materials & Coatings Three Months Ended Nine Months Ended
Percentage change from prior year Sep 30, 2025 Sep 30, 2025
Change in Net Sales from Prior Period due to:
Local price & product mix (5) % (3) %
Currency 1 —
Volume (2) (2)
Total (6) % (5) %
Performance Materials & Coatings net sales were $2,082 million in the third quarter of 2025, down 6 percent from
net sales of $2,214 million in the third quarter of 2024, with local price down 5 percent, volume down 2 percent and
a favorable currency impact of 1 percent. Coatings & Performance Monomers local price decreased across all
geographic regions, primarily in acrylic monomers and architectural coatings. Local price decreased in Consumer
Solutions in all geographic regions and was broad-based across end-markets. Volume decreased in Coatings &
Performance Monomers in all geographic regions except the U.S. & Canada, driven by lower demand for coatings
applications. Volume decreased in Consumer Solutions in all geographic regions except Asia Pacific. Volume
decreased in upstream siloxanes, partially offset by an increase in downstream consumer and electronics and home
care applications. The favorable currency impact was driven by EMEAI in both businesses.
Operating EBIT was $80 million in the third quarter of 2025, down $60 million from Operating EBIT of $140 million in
the third quarter of 2024. Operating EBIT decreased in both businesses primarily due to margin compression and
lower volumes, partially offset by the impact of the Company's cost reduction initiatives.
Performance Materials & Coatings net sales were $6,282 million in the first nine months of 2025, down 5 percent
from net sales of $6,609 million in the first nine months of 2024, with local price down 3 percent and volume down
2 percent. Coatings & Performance Monomers local price decreased across all geographic regions, primarily in
acrylic monomers and architectural coatings. Local price deceased in Consumer Solutions in all geographic regions
and was broad-based across end-markets. Volume decreased in Coatings & Performance Monomers in all
geographic regions except the U.S. & Canada, driven by lower demand for coatings applications. Volume
decreased in Consumer Solutions in all geographic regions except Asia Pacific. Volume decreased in upstream
siloxanes, partially offset by an increase in downstream silicones, led by consumer and electronics applications.
Operating EBIT was $281 million in the first nine months of 2025, down $46 million from Operating EBIT of
$327 million in the first nine months of 2024. Operating EBIT decreased primarily due to margin compression and
lower volumes, partially offset by the impact of the Company's cost reduction initiatives and lower selling, general
and administrative expenses.
Table of Contents
54
-- 54 of 73 --
CORPORATE
Corporate Three Months Ended Nine Months Ended
In millions
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024
Net sales $ 166 $ 187 $ 525 $ 568
Operating EBIT $ (52) $ (64) $ (144) $ (160)
Equity earnings $ 1 $ 2 $ 1 $ 3
Net sales for Corporate, which primarily relate to the Company's insurance operations, were $166 million in the third
quarter of 2025, a decrease from net sales of $187 million in the third quarter of 2024. Net sales were $525 million
in the first nine months of 2025, a decrease from net sales of $568 million in the first nine months of 2024.
Operating EBIT was a loss of $52 million in the third quarter of 2025, compared with a loss of $64 million in the third
quarter of 2024. Operating EBIT was a loss of $144 million in the first nine months of 2025, compared with a loss of
$160 million in the first nine months of 2024. Operating EBIT improved primarily due to lower environmental costs.
CHANGES IN FINANCIAL CONDITION
The Company had cash and cash equivalents of $4,609 million at September 30, 2025 and $2,189 million at
December 31, 2024, of which $2,335 million at September 30, 2025 and $1,427 million at December 31, 2024 was
held by subsidiaries in foreign countries, including U.S. territories. For each of its foreign subsidiaries, Dow makes
an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to
be repatriated to the United States.
Cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries'
operational activities and future foreign investments. Dow has the ability to repatriate additional funds to the United
States, which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state
income taxes and the impact of foreign currency movements. At September 30, 2025, management believed that
sufficient liquidity was available in the United States. The Company has and expects to continue repatriating certain
funds from its non-U.S. subsidiaries that are not needed to finance local operations; however, these particular
repatriation activities have not and are not expected to result in a significant incremental tax liability to the Company.
The Company's cash flows from operating, investing and financing activities, as reflected in the consolidated
statements of cash flows, are summarized in the following table:
Cash Flow Summary Dow Inc. TDCC
Nine Months Ended Nine Months Ended
Sep 30,
2025 Sep 30,
2024 Sep 30,
2025 Sep 30,
2024 In millions
Cash provided by (used for):
Operating activities - continuing operations $ 764 $ 2,092 $ 746 $ 2,116
Operating activities - discontinued operations (16) 8 — —
Operating activities $ 748 $ 2,100 $ 746 $ 2,116
Investing activities $ (1,457) $ (1,456) $ (1,457) $ (1,456)
Financing activities $ 2,941 $ (723) $ 2,943 $ (739)
Cash Flows from Operating Activities
Cash provided by operating activities from continuing operations in the first nine months of 2025 was primarily
driven by the Company's cash earnings, advance payments received from customers related to long-term supply
contracts and dividends from equity method investments, partially offset by cash used for working capital and
performance-based compensation. Cash provided by operating activities from continuing operations in the first nine
months of 2024 was primarily driven by the Company's cash earnings and dividends from equity method
investments, which were partially offset by cash used for working capital and performance-based compensation
payments.
Table of Contents
55
-- 55 of 73 --
Net Working Capital Dow Inc. TDCC
Sep 30,
2025 Dec 31,
2024 Sep 30,
2025 Dec 31,
2024 In millions
Current assets $ 19,646 $ 16,590 $ 19,610 $ 16,565
Current liabilities 10,104 10,288 9,986 10,210
Net working capital $ 9,542 $ 6,302 $ 9,624 $ 6,355
Current ratio 1.94:1 1.61:1 1.96:1 1.62:1
Working Capital Metrics Three Months Ended
Sep 30,
2025 Jun 30,
2025 Sep 30,
2024
Days sales outstanding in trade receivables 48 47 44
Days sales in inventory 67 64 62
Days payables outstanding 64 64 64
Cash provided by (used for) operating activities from discontinued operations in the first nine months of 2025 and
2024 reflected cash payments and receipts for certain agreements and matters related to the separation from
DowDuPont Inc. ("DowDuPont").
Cash Flows from Investing Activities
Cash used for investing activities in the first nine months of 2025 and 2024 was primarily for capital expenditures
and purchases of investments, which were partially offset by proceeds from sales and maturities of investments.
The first nine months of 2025 also included a cash inflow related to the sale of the soil fumigation product line and
certain related assets, proceeds from incentives related to capital expenditures and the divestiture of the Company's
ownership interest in DowAksa. The first nine months of 2024 also included the acquisition of Circulus Holdings,
PBLLC, a U.S. mechanical recycling company.
The Company's capital expenditures were $1,911 million in the first nine months of 2025, compared with
$2,173 million in the first nine months of 2024. The Company has reduced its expected full year capital spending to
approximately $2.5 billion. The primary driver for the decrease is the Company’s decision to delay construction of
the Fort Saskatchewan Path2Zero project until market conditions improve. As evidenced across this and prior
economic cycles, the Company will proactively adjust its spending as economic conditions evolve.
Cash Flows from Financing Activities
Cash provided by financing activities in the first nine months of 2025 was primarily related to proceeds from the sale
of a minority stake in the Company's consolidated infrastructure entity and proceeds from the issuance of long-term
debt, which were partially offset by payments on long-term debt. In addition, Dow Inc. included cash outflows for
dividends paid to stockholders, including the impact of a 50 percent reduction to dividends paid in the third quarter
of 2025, and TDCC included cash outflows for dividends paid to Dow Inc. Cash used for financing activities in the
first nine months of 2024 for Dow Inc. was primarily related to dividends paid to stockholders, purchases of treasury
stock and payments on long-term debt, which were partially offset by proceeds from issuance of long-term debt.
Cash used for financing activities in the first nine months of 2024 for TDCC was primarily related to dividends paid
to Dow Inc. and payments on long-term debt, which were partially offset by proceeds from issuance of long-term
debt.
Dow Inc. Non-GAAP Cash Flow Measures
Free Cash Flow
Dow defines Free Cash Flow as "Cash provided by operating activities - continuing operations," less capital
expenditures. Under this definition, Free Cash Flow represents the cash generated by Dow from operations after
investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represents
the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial
measure used in the Company's financial planning process.
Operating EBITDA
Dow defines Operating EBITDA as earnings (i.e., "Income (loss) before income taxes") before interest, depreciation
and amortization, excluding the impact of significant items.
Table of Contents
56
-- 56 of 73 --
Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA)
Dow defines Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA) as "Cash provided by
operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow
Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its
earnings into cash flow.
These financial measures are not recognized in accordance with accounting principles generally accepted in the
United States of America (“GAAP”) and should not be viewed as alternatives to GAAP financial measures of
performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly,
Dow's definitions may not be consistent with the methodologies used by other companies.
Reconciliation of Free Cash Flow Nine Months Ended
Sep 30,
2025 Sep 30,
2024 In millions
Cash provided by operating activities - continuing operations (GAAP) $ 764 $ 2,092
Capital expenditures (1,911) (2,173)
Free Cash Flow (non-GAAP) $ (1,147) $ (81)
Sep 30,
2025 Sep 30,
2024 In millions
Net income (loss) (GAAP) $ (967) $ 1,236
+ Provision for income taxes 4 145
Income (loss) before income taxes $ (963) $ 1,381
- Interest income 114 143
+ Interest expense and amortization of debt discount 646 595
- Significant items ¹ (820) (301)
Operating EBIT (non-GAAP) $ 389 $ 2,134
+ Depreciation and amortization 2,126 2,143
Operating EBITDA (non-GAAP) $ 2,515 $ 4,277
Cash provided by operating activities - continuing operations (GAAP) $ 764 $ 2,092
Cash flow from operations to net income (GAAP) 2 N/A 169.3 %
Cash Flow Conversion (Cash flow from operations to Operating EBITDA) (non-GAAP) 30.4 % 48.9 %
Reconciliation of Cash Flow Conversion (Cash Flow from Operations to Operating
EBITDA)
Nine Months Ended
1. The nine months ended September 30, 2025 includes: severance and related benefit costs, costs associated with exit and disposal activities
and impairment charges related to the 2025 Restructuring Program; implementation costs associated with the Company's 2025 Restructuring
Program and the sale of membership interests of Diamond Infrastructure Solutions; a gain on the sale of the soil fumigation product line and
divestiture of ownership interest in DowAksa; a gain associated with the reassessment of liabilities for certain accrued Groundwater Matters,
partially offset by the settlement of a separate claim related to Groundwater Matters; charges associated with agreements entered into with
DuPont de Nemours, Inc. and Corteva, Inc. as part of the separation and distribution; charges related to an arbitration agreement for historical
product claims from a divested business; a loss on early extinguishment of debt; restructuring charges and implementation and efficiency costs
associated with the Company's 2023 Restructuring Program. The nine months ended September 30, 2024 includes restructuring charges and
implementation and efficiency costs associated with the Company's 2023 Restructuring Program and impairment charges related to write-
downs of certain manufacturing assets. See Note 23 to the Consolidated Financial Statements for additional information.
2. Cash flow from operations to net income is not applicable for the nine months ended September 30, 2025 due to a net loss for the period.
Liquidity & Financial Flexibility
The Company’s primary source of incremental liquidity is cash flows from operating activities. The generation of
cash from operations over the economic cycle and the Company's ability to access capital markets is expected to
meet the Company’s cash requirements for working capital, capital expenditures, debt maturities, contributions to
pension plans, dividend distributions to stockholders, share repurchases and other needs. In addition to cash from
operating activities, the Company’s current liquidity sources also include TDCC's U.S. and Euromarket commercial
paper programs, committed and uncommitted credit facilities, committed accounts receivable facilities, a medium-
term notes program, a U.S. retail note program (“InterNotes®”) and other debt markets.
Table of Contents
57
-- 57 of 73 --
The Company continues to maintain a strong financial position with all of its committed credit facilities undrawn and
fully available at September 30, 2025. Cash and committed and available forms of liquidity were $14.5 billion at
September 30, 2025. The Company also has no substantive long-term debt maturities due until 2027. As a well-
known seasoned issuer, the Company has ready access to debt capital markets, subject to market conditions, as an
additional source of liquidity. Additional details on sources of liquidity are as follows:
Commercial Paper
TDCC issues promissory notes under its U.S. and Euromarket commercial paper programs. TDCC had no
commercial paper outstanding at September 30, 2025. TDCC maintains access to the commercial paper market at
competitive rates. Amounts outstanding under TDCC's commercial paper programs during the period may be
greater or less than the amount reported at the end of the period. TDCC did not issue commercial paper
subsequent to September 30, 2025.
Committed Credit Facilities
The Company also has the ability to access liquidity through TDCC's committed and available credit facilities. At
September 30, 2025, TDCC had total committed and available credit facilities of $8.4 billion.
Uncommitted Credit Facilities
The Company has entered into various uncommitted bilateral credit arrangements as a potential source of excess
liquidity. These lines can be used to support short-term liquidity needs and for general purposes. The Company had
no drawdowns outstanding at September 30, 2025.
Accounts Receivable Securitization Facilities
In addition to the above credit facilities, the Company maintains a committed accounts receivable facility in the
United States where eligible trade accounts receivable, up to $900 million, may be sold at any point in time. The
Company also maintains a committed accounts receivable facility in Europe where eligible trade accounts
receivable, up to €500 million, may be sold at any point in time. These facilities are set to expire in November 2025
and are expected to be renewed in the fourth quarter. In the first nine months of 2025, there were $106 million in
sales of receivables under the U.S. and Europe committed accounts receivable facilities ($289 million in sales of
receivables in the first nine months of 2024). No sold receivables were outstanding with the facilities at
September 30, 2025.
In addition, the Company has an uncommitted accounts receivable facility in the United States providing additional
liquidity. This facility is set to expire in November 2025 and is expected to be renewed in the fourth quarter. Sales of
receivables under this facility were $147 million in the first nine months of 2025 ($378 million in sales of receivables
in the first nine months of 2024). No sold receivables were outstanding with the facility at September 30, 2025. See
Note 12 to the Consolidated Financial Statements for additional information.
Early Settlement of Letters of Credit
The Company utilizes, from time-to-time, letters of credit discounting programs to manage and expedite the
settlement of letters of credit in certain regions. These letters of credit are associated with accounts receivable and
the Company retains no interest in the transferred letters of credit or receivables once sold.
Accounts Receivable Discounting Facilities
The Company has access to accounts receivable discounting facilities, under which receivables are transferred with
limited recourse. The Company retains no interest in the transferred receivables once sold. Sales of receivables
under this facility were $285 million in the first nine months of 2025 ($581 million sales of receivables in the first nine
months of 2024). At September 30, 2025, approximately $6 million of sold receivables were outstanding. See
Note 12 to the Consolidated Financial Statements for additional information.
The Company maintains these facilities and also participates in certain customers’ supply chain financing and other
early pay programs as a routine source of working capital.
Company-Owned Life Insurance
The Company has investments in company-owned life insurance ("COLI") policies, which are recorded at their cash
surrender value as of each balance sheet date. The Company has the ability to monetize its investment in its COLI
policies as an additional source of liquidity. At September 30, 2025, the Company had monetized $197 million of its
existing COLI policies' surrender value (zero at December 31, 2024). See Note 6 to the Consolidated Financial
Statements for additional information.
Table of Contents
58
-- 58 of 73 --
Shelf Registration - U.S.
On June 13, 2025, Dow Inc. and TDCC filed a shelf registration statement with the U.S. Securities and Exchange
Commission. The shelf indicates that Dow Inc. may offer common stock; preferred stock; depositary shares; debt
securities; guarantees; warrants to purchase common stock, preferred stock and debt securities; and stock
purchase contracts and stock purchase units, with pricing and availability of any such offerings depending on
market conditions. The shelf also indicates that TDCC may offer debt securities, guarantees and warrants to
purchase debt securities, with pricing and availability of any such offerings depending on market conditions. On
July 25, 2025, TDCC filed a prospectus supplement under this shelf registration to register an undetermined amount
of securities for issuance under InterNotes®. Also, on July 25, 2025, TDCC filed a prospectus supplement under
this shelf registration to register an undetermined amount of securities for issuance under a medium-term notes
program.
Debt
As the Company continues to maintain its strong balance sheet and financial flexibility, management is focused on
net debt (a non-GAAP financial measure), as the Company believes this is the best representation of its financial
leverage at this point in time. As shown in the following table, net debt is equal to total gross debt minus "Cash and
cash equivalents" and "Marketable securities."
Total Debt Dow Inc. TDCC
Sep 30,
2025 Dec 31,
2024 Sep 30,
2025 Dec 31,
2024 In millions
Notes payable $ 133 $ 135 $ 133 $ 135
Long-term debt due within one year 413 497 413 497
Long-term debt 17,709 15,711 17,709 15,711
Gross debt $ 18,255 $ 16,343 $ 18,255 $ 16,343
- Cash and cash equivalents 4,609 2,189 4,609 2,189
- Marketable securities 1 497 383 497 383
Net debt $ 13,149 $ 13,771 $ 13,149 $ 13,771
Total equity $ 19,064 $ 17,851 $ 19,280 $ 18,032
Gross debt as a percent of total capitalization 48.9 % 47.8 % 48.6 % 47.5 %
Net debt as a percent of total capitalization 40.8 % 43.5 % 40.5 % 43.3 %
1. Included in "Other current assets" in the consolidated balance sheets.
The Company may at any time repurchase certain debt securities in the open market or in privately negotiated
transactions subject to: the applicable terms under which any such debt securities were issued, certain internal
approvals of the Company, and applicable laws and regulations of the relevant jurisdiction in which any such
potential transactions might take place. This in no way obligates the Company to make any such repurchases nor
should it be considered an offer to do so.
TDCC's public debt instruments and primary, private credit agreements contain, among other provisions, certain
customary restrictive covenant and default provisions. TDCC's most significant debt covenant with regard to its
financial position is the obligation to maintain the ratio of its consolidated indebtedness to consolidated capitalization
at no greater than 0.70 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year
Competitive Advance and Revolving Credit Facility Agreement ("Revolving Credit Agreement") equals or exceeds
$500 million. The ratio of TDCC's consolidated indebtedness to consolidated capitalization as defined in the
Revolving Credit Agreement was 0.46 to 1.00 at September 30, 2025. Management believes TDCC was in
compliance with all of its covenants and default provisions at September 30, 2025. For information on TDCC's debt
covenants and default provisions, see Note 14 to the Consolidated Financial Statements included in the 2024 10-K.
There were no material changes to the debt covenants and default provisions related to TDCC’s outstanding long-
term debt and primary, private credit agreements in the first nine months of 2025.
In the first quarter of 2025, the Company completed debt neutral liability management activities. The Company
issued $1 billion of senior unsecured notes. The offering included $400 million aggregate principal amount of
5.35 percent notes due 2035 and $600 million aggregate principal amount of 5.95 percent notes due 2055. The
Company used the proceeds to complete cash tender offers for certain debt securities. In total, $943 million
aggregate principal amount was tendered and retired. As a result, the Company recognized a pretax loss of
Table of Contents
59
-- 59 of 73 --
$60 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated
statements of income, related to Corporate.
In the third quarter of 2025, the Company issued $1.4 billion of senior unsecured notes. The offering included
$750 million aggregate principal amount of 4.80 percent notes due 2031 and $650 million aggregate principal
amount of 5.65 percent notes due 2036. Additionally, the Company redeemed $55 million aggregate principal
amount of 9.40 percent notes due 2039. As a result of the redemption, the Company recognized a pretax loss of
$18 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated
statements of income, related to Corporate.
In the first nine months of 2025, the Company issued an aggregate principal amount of $252 million of InterNotes®.
Additionally, the Company repaid $125 million of long-term debt at maturity.
While taking into consideration the current economic environment, management expects that the Company will
continue to have sufficient liquidity and financial flexibility to meet all of its business obligations.
Credit Ratings
At September 30, 2025, TDCC's credit ratings were as follows:
Credit Ratings Long-Term Rating Short-Term Rating Outlook
Fitch Ratings BBB F2 Stable
Moody’s Ratings Baa2 P-2 Negative
Standard & Poor’s BBB A-2 Negative
On February 21, 2025, Standard & Poor's affirmed TDCC's BBB and A-2 rating, and revised its outlook to negative
from stable. Standard & Poor's decision was made as part of their annual review process and reflects the
Company's supportive financial policies, scale, liquidity and cost-advantaged footprint.
On July 7, 2025, Moody's Ratings announced a long-term credit rating change for TDCC from Baa1 to Baa2 and
affirmed TDCC's P-2 rating and its outlook of negative. On July 31, 2025, Fitch Ratings announced a long-term
credit rating change for TDCC from BBB+ to BBB and a short-term credit rating change from F1 to F2, with its
outlook remaining stable. The credit rating agencies' decisions were made to reflect the impact of current market
conditions on the Company's operating results and cash flow, including the impact of global trade policy uncertainty
and capacity additions in the industry, while recognizing the Company's strong asset base, strategic cost actions
and long-term commitment to maintaining investment-grade quality.
Dividends
Dow Inc.
Dow Inc. has paid dividends on a quarterly basis since the separation from DowDuPont and expects to continue to
do so, subject to approval by the Board. On July 24, 2025, the Company announced a 50 percent reduction to its
quarterly dividend. The following table summarizes dividends declared and paid to common stockholders of record
in 2025:
Dow Inc. Dividends Declared and Paid
Declaration Date Record Date Payment Date Amount (per share)
February 13, 2025 February 28, 2025 March 14, 2025 $ 0.70
April 10, 2025 May 30, 2025 June 13, 2025 $ 0.70
July 24, 2025 August 29, 2025 September 12, 2025 $ 0.35
October 9, 2025 November 28, 2025 December 12, 2025 $ 0.35
TDCC
TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders and share repurchases, as
approved by the Board, as well as certain governance expenses. Funding is accomplished through intercompany
loans. TDCC's Board reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans.
For the three months ended September 30, 2025, TDCC declared a dividend of $240 million and paid a dividend of
$252 million to Dow Inc. ($1,225 million of dividend declared and $1,237 million of dividend paid for the nine months
Table of Contents
60
-- 60 of 73 --
ended September 30, 2025). At September 30, 2025, TDCC's intercompany loan balance with Dow Inc. was
insignificant.
Share Repurchase Program
On April 13, 2022, the Board approved a share repurchase program authorizing up to $3 billion for the repurchase
of the Company's common stock, with no expiration date. The Company did not repurchase any of its common
stock in the third quarter of 2025 (zero in the first nine months of 2025). At September 30, 2025, approximately
$931 million of the share repurchase program authorization remained available for repurchases. As previously
announced, the Company intends to repurchase shares at a minimum to cover dilution over the economic cycle.
The Company may from time to time expand its share repurchases beyond dilution, based on a number of factors
including macroeconomic conditions, free cash flow generation, and the Dow share price. Any share repurchases,
when coupled with the Company's dividends, are intended to implement the long-term strategy of targeting
shareholder remuneration of approximately 65 percent of Operating Net Income over the economic cycle.
Pension Plans
The Company has both funded and unfunded defined benefit pension plans that cover employees in the United
States and a number of other countries. The Company's funding policy is to contribute to funded plans when
pension laws and/or economics either require or encourage funding.
As part of its ongoing pension derisking initiatives, the Company initiated the termination of certain U.S. tax-qualified
pension plans which include the tax-qualified benefit obligations for substantially all employees hired after
January 1, 2008, who earned benefits based on a set percentage of annual pay, plus interest. As part of the plan
termination process, the Company offered participants of these plans annuity or lump sum distribution options. Final
asset distributions are expected to be paid from plan assets in the fourth quarter of 2025. The Company is also
pursuing other pension derisking opportunities, including annuitization and risk transfer of certain other pension
liabilities. These actions, if executed and inclusive of the termination of certain U.S. tax-qualified pension plans
discussed above, are expected to result in non-operating and non-cash settlement charges in the range of
$275 million to $350 million in the fourth quarter of 2025.
See Note 18 to the Consolidated Financial Statements and Note 19 to the Consolidated Financial Statements
included in the 2024 10-K for additional information related to the Company's pension plans.
Restructuring
The 2025 Restructuring Program is expected to result in additional cash expenditures of approximately $650 million
primarily over the next four years and consist primarily of severance and related benefits costs, implementation
costs related to decommissioning and demolition and additional costs associated with exit and disposal activities.
Restructuring implementation costs totaled $5 million and $10 million for the three and nine months ended
September 30, 2025.
Restructuring implementation and efficiency costs related to the 2023 Restructuring Program were zero and
$50 million for the three and nine months ended September 30, 2025, respectively ($55 million and $157 million for
the three and nine months ended September 30, 2024, respectively).
The Company expects to incur additional costs in the future related to its restructuring activities, which will be
recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary
termination benefits related to its other optimization activities. These costs cannot be reasonably estimated at this
time. See Note 5 to the Consolidated Financial Statements for additional information on the Company's restructuring
activities.
Table of Contents
61
-- 61 of 73 --
Contractual Obligations
Information related to the Company’s contractual obligations, commercial commitments and expected cash
requirements for interest can be found in Notes 14, 15, 16 and 19 to the Consolidated Financial Statements
included in the 2024 10-K. With the exception of the items noted below, there have been no material changes in the
Company’s contractual obligations since December 31, 2024.
Contractual Obligations at Sep 30, 2025 Payments Due In
In millions 2025 2026-2027 2028-2029 2030 and
beyond Total
Dow Inc.
Long-term debt obligations 1 $ 245 $ 989 $ 1,811 $ 15,308 $ 18,353
Expected cash requirements for interest 2 271 1,733 1,626 10,173 13,803
Operating leases 3 102 666 384 481 1,633
Purchase obligations 4 706 4,721 3,667 15,983 25,077
Total $ 1,324 $ 8,109 $ 7,488 $ 41,945 $ 58,866
1. Excludes unamortized debt discount and issuance costs of $231 million. Includes finance lease obligations of $1,079 million and net fair value
hedge adjustment gains of $35 million.
2. Cash requirements for interest on long-term debt was calculated using current interest rates at September 30, 2025, and includes $134 million
of various floating rate notes.
3. Includes imputed interest of $263 million.
4. Includes outstanding purchase orders and other commitments greater than $1 million obtained through a survey conducted within the
Company. The increase from December 31, 2024 was primarily due to supply agreements related to the Company's Fort Saskatchewan
Path2Zero project and contract term extensions.
Fair Value Measurements
See Note 21 to the Consolidated Financial Statements for information concerning fair value measurements.
OTHER MATTERS
Critical Accounting Estimates
The preparation of financial statements and related disclosures in accordance with accounting principles generally
accepted in the United States of America requires management to make judgments, assumptions and estimates
that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the
Consolidated Financial Statements included in the 2024 10-K describes the significant accounting policies and
methods used in the preparation of the consolidated financial statements. The Company’s critical accounting
policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion
and Analysis of Financial Condition and Results of Operations included in the 2024 10-K. Since December 31,
2024, there have been no material changes in the Company’s accounting policies that are impacted by judgments,
assumptions and estimates.
2025 Goodwill Impairment Testing
In the second quarter of 2025, the Board approved actions to shut down certain upstream manufacturing assets. As
a result of the announced actions, the Company identified potential indicators of goodwill impairment and evaluated
whether the fair value of any reporting unit may be less than its carrying amount. The Company identified one
reporting unit for which a quantitative interim goodwill impairment test was required. The results of the quantitative
impairment test concluded that no goodwill impairment existed, as the fair value exceeded the carrying value of the
reporting unit.
In the third quarter of 2025, as a result of continued macroeconomic challenges, the Company evaluated whether
the fair value of any reporting unit may be less than its carrying amount. The Company identified one reporting unit
for which a quantitative interim goodwill impairment test was required. The results of the quantitative impairment test
concluded that no goodwill impairment existed, as the fair value exceeded the carrying value of the reporting unit.
The Company continues to monitor key factors that could impact the fair value of its reporting units, including
changes in macroeconomic conditions or industry-specific trends, deterioration in financial performance, increases
in market interest rates or adverse changes in regulatory or competitive environments. If these, or other adverse
events occur, it may be necessary to perform additional impairment testing, which could result in a future goodwill
impairment charge. For additional information, see Notes 5 and 11 to the Consolidated Financial Statements.
Table of Contents
62
-- 62 of 73 --
Asbestos-Related Matters of Union Carbide Corporation
Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts
during the past several decades. These suits principally allege personal injury resulting from exposure to
asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily
relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on
Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former
Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate
that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted
from exposure to Union Carbide’s products.
The table below provides information regarding asbestos-related claims pending against Union Carbide and
Amchem based on criteria developed by Union Carbide and its external consultants:
Asbestos-Related Claim Activity 2025 2024
Claims unresolved at Jan 1 5,813 6,367
Claims filed 3,407 3,472
Claims settled, dismissed or otherwise resolved (2,719) (4,469)
Claims unresolved at Sep 30 6,501 5,370
Claimants with claims against both Union Carbide and Amchem (1,192) (963)
Individual claimants at Sep 30 5,309 4,407
Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a
result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular
defendant, even when specific damages are alleged with respect to a specific disease or injury. For these reasons
and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the
damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential
asbestos-related liability.
For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 14 to the
Consolidated Financial Statements; Part II, Item 1. Legal Proceedings; and Note 15 to the Consolidated Financial
Statements included in the 2024 10-K.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See Note 20 to the Consolidated Financial Statements and Part II, Item 7A. Quantitative and Qualitative Disclosures
About Market Risk in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended
December 31, 2024, for information on the Company's utilization of financial instruments and an analysis of the
sensitivity of these instruments.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this Quarterly Report on Form 10-Q, Dow Inc. and The Dow Chemical
Company (the "Companies") carried out an evaluation, under the supervision and with the participation of the
Companies' Disclosure Committee and the Companies' management, including the Chief Executive Officer and the
Chief Financial Officer, of the effectiveness of the design and operation of the Companies' disclosure controls and
procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the
Chief Executive Officer and the Chief Financial Officer concluded that the Companies' disclosure controls and
procedures were effective.
Changes in Internal Control Over Financial Reporting
There were no changes in the Companies' internal control over financial reporting identified in connection with the
evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the
quarter ended September 30, 2025, that have materially affected, or are reasonably likely to materially affect, the
Companies' internal control over financial reporting.
Table of Contents
63
-- 63 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Asbestos-Related Matters of Union Carbide Corporation
No material developments regarding this matter occurred in the first nine months of 2025. For a current status of
this matter, see Note 14 to the Consolidated Financial Statements.
Securities Litigation
On August 29, 2025, a putative securities class action was filed in the U.S. District Court for the Eastern District of
Michigan alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 against the
Company, its Chief Executive Officer, its Chief Financial Officer, and its Chief Operating Officer due to alleged false
and misleading statements regarding the Company’s ability to navigate macroeconomic and tariff-related pressures,
competitive and pricing pressures and softening demand, and the Company’s ability to sustain its dividend, which
allegedly caused the Company’s securities to trade at artificially inflated prices. The action seeks unspecified
compensatory damages.
Subsequently, three putative shareholder derivative actions were filed in the U.S. District Court for the Eastern
District of Michigan on September 5, 2025, September 11, 2025, and September 18, 2025, which are based on the
same alleged facts and circumstances as the above-referenced securities class action, and name certain of the
Company's officers, including its Chief Executive Officer, its Chief Financial Officer, and its Chief Operating Officer,
and members of its Board of Directors, as defendants. The derivative actions assert claims for violations of the
Securities Exchange Act of 1934, breach of fiduciary duty, and other claims, and seek to recover damages on behalf
of the Company.
Environmental Proceedings
In October 2023, Region 6 of the U.S. Environmental Protection Agency ("EPA") conducted an inspection of the
Company’s Louisiana Operations under the EPA’s Risk Management Program ("RMP"). The inspection was initiated
due to an incident at the Company's Glycol-2 unit in Plaquemine, Louisiana, on July 14, 2023, as previously
disclosed by the Company. The EPA published its inspection report on January 26, 2024. On January 3, 2025, the
Company received a Notice Letter from the EPA’s enforcement branch, which formally alleged 21 violations of RMP
and Clean Air Act requirements and offered the Company an opportunity to confer with the EPA. Discussions
between the Company and EPA are ongoing.
On September 29, 2025, the EPA informed the Company of its intention to seek a civil penalty for benzene
emissions in Orange, Texas, alleged to be in excess of action levels set out in an existing 2021 consent decree.
Discussions between the Company and EPA are ongoing.
On October 14, 2025, the EPA sent Dow Silicones Corporation a letter demanding payment of $329,000 in
stipulated penalties incurred under the terms of the January 24, 2020 consent decree in United States of America,
et al., v. Dow Silicones Corporation. The stipulated penalties result from self-reported violations of consent decree
provisions since 2020. Payment of this stipulated penalty will resolve these violations and is a necessary step prior
to termination of the consent decree.
Table of Contents
64
-- 64 of 73 --
ITEM 1A. RISK FACTORS
Since December 31, 2024, there have been no material changes to the Company's Risk Factors, except as noted
below, which was updated in the first, second and third quarters of 2025:
Global Economic Considerations: The Company operates in a global, competitive environment which gives
rise to operating and market risk exposure.
The Company sells its broad range of products and services in a competitive, global environment, and competes
worldwide for sales on the basis of product quality, price, technology and customer service. Increased levels of
competition has resulted in lower prices and lower sales volume, which have had a negative impact on the
Company’s results of operations. These factors are expected to continue and may worsen in the near term, which
could continue to challenge the Company's ongoing results of operations. To address these challenges amidst the
ongoing macroeconomic uncertainty, the Company has taken targeted cost reduction initiatives and other actions to
advance its balanced capital allocation approach and enhance financial flexibility, and will continue to seek
additional actions to mitigate the impact of macroeconomic uncertainty. Unforeseen macroeconomic conditions
could result in additional actions that could adversely affect equity performance until market conditions improve. For
additional information, see Note 5 to the Consolidated Financial Statements and Part I Item 2. Management's
Discussion and Analysis of Financial Condition and Results of Operations.
Sales of the Company's products are also subject to extensive federal, state, local and foreign laws and regulations;
trade agreements; import and export controls; taxes; and duties and tariffs. The imposition of additional regulations,
controls, taxes, duties and tariffs or changes to bilateral and regional trade agreements could also result in lower
sales volume, which could negatively impact the Company’s results of operations.
During 2025, the United States changed its long-standing trade policies and announced significant new tariffs on
virtually all imported goods, with the exception of certain goods that are compliant with the United States-Mexico-
Canada Agreement, a trade agreement which became effective in 2020. These actions triggered the negotiation of
new trade agreements with certain U.S. trading partners. While these negotiations resulted in the reduction of
certain recently imposed tariffs, the average U.S. tariff rate remains at its highest level since the 1930s. In response
to the changes in U.S. trade policies, certain U.S. trading partners imposed retaliatory tariffs on U.S. imports. Shifts
in tariffs, import/export restrictions, trade sanctions, sector specific trade barriers, and other governmental trade
actions, whether enacted by the United States or other countries, and the associated uncertainty of long-term trade
policies, could impact the Company's sales volume, sales price, and production and other costs. Changes in trade
policies may also cause disruptions to material sourcing and availability, global supply chains and logistics and
access to end markets. Additionally, changes in U.S. trade policy and associated responses from trading partners
may create shifts in global market dynamics, disrupt the long-term planning process for governments and private
enterprises and result in continued global financial market volatility. The impact of these changes in trade policies
and the resulting trade and market uncertainty could have a negative impact on the Company’s results of
operations.
Economic conditions around the world, and in certain industries and geographic regions in which the Company does
business, also impact sales price and volume and the efficacy of the Company's supply chain. For example, long-
term market uncertainty, an economic downturn driven by trade policies and inflationary pressures, and higher input
costs have reduced demand for the Company's products, resulting in decreased sales price and volume. Adverse
economic conditions have also caused supply chain constraints. These factors have had and are continuing to have
a negative impact on the Company's results of operations. Additionally, political tensions; war, including the ongoing
conflicts in the Middle East and between Russia and Ukraine with the related sanctions and export restrictions;
terrorism; epidemics; pandemics; or political instability in the geographic regions or industries in which the Company
sells its products could further reduce demand for the Company's products and result in decreased sales price and
volume or supply chain disruptions, which could have a negative impact on the Company’s results of operations.
The Russia-Ukraine conflict has been ongoing for more than three years since Russia's February 2022 invasion of
Ukraine, and although there have been recent efforts to seek a resolution, it remains unclear if these will be
successful. In light of sanctions imposed by the United States, Canada, the European Union and other countries as
a result of this conflict, Dow ceased in-bound investment to Russia and maintains reasonable, risk-based measures
to ship into Russia only limited goods that comply with applicable legal restrictions. These actions have not had and
are not expected to have a material impact on the Company's financial condition or results of operations. The
situation remains fluid and the ongoing conflict may result in additional economic sanctions or other measures,
which could have a negative impact on the Company’s financial condition, results of operations and cash flows.
Table of Contents
65
-- 65 of 73 --
These impacts could include decreased sales; supply chain and logistics disruptions; volatility in foreign exchange
rates and interest rates; inflationary pressures on and availability of raw materials and energy, most notably in
Europe; and heightened cybersecurity threats. Further, the intensity and duration of conflicts in the Middle East and
potential expansion of hostilities in the region are difficult to predict and could disrupt the Company's supply chain
operations, which could have a negative impact on the Company's results of operations.
In addition, volatility and disruption of financial markets could limit the ability of Dow's customers and suppliers to
obtain adequate financing to maintain operations, which could result in a decrease in sales volume and have a
negative impact on the Company’s results of operations. The Company’s global business operations also give rise
to market risk exposure related to changes in inflation, foreign currency exchange rates, including the impact of
foreign currency exchange rates resulting from highly inflationary economies such as Argentina, interest rates,
commodity prices and other market factors such as equity prices. To manage such risks, the Company enters into
hedging and other investment transactions, where deemed appropriate, pursuant to established guidelines and
policies. If the Company fails to effectively manage such risks, it could have a negative impact on its results of
operations.
Supply/Demand Balance: Earnings generated by the Company's products vary based in part on the balance
of supply relative to demand within the industry.
The balance of supply relative to demand within the industry has been and continues to be significantly impacted by
the addition of new capacity, especially for basic commodities where capacity is generally added in large increments
as world-scale facilities are built. This has resulted in excess capacity which has disrupted and continues to disrupt
regional industry supply and demand balances, particularly in Europe, the Middle East, Africa and India ("EMEAI")
and Asia Pacific, resulting in downward pressure on prices and decreased operating rates, which has and continues
to negatively impact the Company’s results of operations.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table provides information regarding purchases of Dow Inc. common stock by the Company during the
three months ended September 30, 2025:
Issuer Purchases of Equity Securities
Total number of shares
purchased as part of the
Company's publicly
announced share
repurchase program
Approximate dollar value of
shares that may yet be
purchased under the
Company's publicly
announced share
repurchase program 1
(In millions) Period
Total number of
shares
purchased Average price
paid per share
July 2025 — $ — — $ 931
August 2025 — $ — — $ 931
September 2025 — $ — — $ 931
Third quarter 2025 — $ — — $ 931
1. On April 13, 2022, the Dow Inc. Board approved a share repurchase program authorizing up to $3.0 billion for the repurchase of the
Company's common stock, with no expiration date.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
During the third quarter of 2025, the Company's directors and officers (as defined in Rule 16a-1(f) of the Securities
Exchange Act of 1934, as amended) did not adopt, terminate or modify Rule 10b5-1 or non-rule 10b5-1 trading
arrangements (as defined in Item 408 of Regulation S-K).
Table of Contents
66
-- 66 of 73 --
ITEM 6. EXHIBITS
EXHIBIT NO. DESCRIPTION
4.3 Dow Inc. agrees to provide the SEC, on request, copies of all other such indentures and
instruments that define the rights of holders of long-term debt of Dow Inc. and its consolidated
subsidiaries, including The Dow Chemical Company, pursuant to Item 601(b)(4)(iii)(A) of
Regulation S-K.
23 * Ankura Consulting Group, LLC's Consent.
31.1 * Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 * Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 * Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 * Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS The instance document does not appear in the Interactive Data File because its XBRL tags are
embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Document.
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 Cover Page Interactive Data File. The cover page interactive data file does not appear in the
Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
* Filed herewith
TRADEMARK LISTING
The following registered trademark of InspereX Holdings LLC appears in this report: InterNotes
® ™ Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow, except as otherwise specified.
Table of Contents
67
-- 67 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to
be signed on its behalf by the undersigned thereunto duly authorized.
DOW INC.
THE DOW CHEMICAL COMPANY
Date: October 24, 2025
/s/ ANDREA L. DOMINOWSKI
Andrea L. Dominowski
Controller and Vice President of
Controllers
(Authorized Signatory and
Principal Accounting Officer)
Table of Contents
68
-- 68 of 73 --
Ankura Consulting Group, LLC's Consent EXHIBIT 23
Ankura Consulting Group, LLC (“Ankura”) hereby consents to the use of Ankura's name and the reference to
Ankura's reports in this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company for the period
ended September 30, 2025, and the incorporation by reference thereof in the following Registration Statements of
Dow Inc. and The Dow Chemical Company:
DOW INC.
Form S-3:
Nos. 333-230668
333-265556
333-288028
Form S-8:
Nos. 333-220352-01
333-230680
333-230681
333-255472
333-255473
THE DOW CHEMICAL COMPANY
Form S-3:
No. 333-265556-01
333-288028-01
Form S-4:
No. 333-234108
Form S-8:
Nos. 33-61795
333-40271
333-91027
333-103519
333-220352
Date: October 24, 2025
/s/ AMY BROCKMAN
Amy Brockman
Senior Managing Director
Ankura Consulting Group, LLC
69
-- 69 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries EXHIBIT 31.1
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Jim Fitterling, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrants as
of, and for, the periods presented in this report;
4. The registrants' other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrants and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the registrants, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
c. Evaluated the effectiveness of the registrants' disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrants' internal control over financial reporting that occurred
during the registrants' most recent fiscal quarter (the registrants' fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrants' internal
control over financial reporting; and
5. The registrants' other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrants' auditors and the audit committee of registrants' board of
directors (or persons performing the equivalent function):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrants' ability to record, process,
summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrants' internal control over financial reporting.
Date: October 24, 2025
/s/ JIM FITTERLING
Jim Fitterling
Chair and Chief Executive Officer
70
-- 70 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries EXHIBIT 31.2
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Jeffrey L. Tate, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Dow Inc. and The Dow Chemical Company;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrants as
of, and for, the periods presented in this report;
4. The registrants' other certifying officer and I are responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrants and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to
be designed under our supervision, to ensure that material information relating to the registrants, including
its consolidated subsidiaries, is made known to us by others within those entities, particularly during the
period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
c. Evaluated the effectiveness of the registrants' disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrants' internal control over financial reporting that occurred
during the registrants' most recent fiscal quarter (the registrants' fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to materially affect, the registrants' internal
control over financial reporting; and
5. The registrants' other certifying officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrants' auditors and the audit committee of registrants' board of
directors (or persons performing the equivalent function):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrants' ability to record, process,
summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrants' internal control over financial reporting.
Date: October 24, 2025
/s/ JEFFREY L. TATE
Jeffrey L. Tate
Chief Financial Officer
71
-- 71 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries EXHIBIT 32.1
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Jim Fitterling, Chair and Chief Executive Officer of Dow Inc. and The Dow Chemical Company (the “Companies”),
certify that:
1. The Quarterly Report on Form 10-Q of the Companies for the quarter ended September 30, 2025 as filed with
the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Companies.
Date: October 24, 2025
/s/ JIM FITTERLING
Jim Fitterling
Chair and Chief Executive Officer
72
-- 72 of 73 --
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries EXHIBIT 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
I, Jeffrey L. Tate, Chief Financial Officer of Dow Inc. and The Dow Chemical Company (the “Companies”), certify
that:
1. The Quarterly Report on Form 10-Q of the Companies for the quarter ended September 30, 2025 as filed with
the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Companies.
Date: October 24, 2025
/s/ JEFFREY L. TATE
Jeffrey L. Tate
Chief Financial Officer
73
-- 73 of 73 --